http://publicationslist.org/data/jrv/atom.xml Jennifer Verani//publicationslist.org/jrv$basepathfavicon.icoRecent additions to Jennifer Verani's PublicationsList.org page//publicationslist.org/publications.png2026-04-01T22:46:21Z //publicationslist.org/jrv/refid126 2026-04-01T22:30:42Z

Mozambique introduced the 10-valent pneumococcal conjugate vaccine (PCV10) in 2013. We aimed to assess PCV10 effectiveness against radiologically confirmed pneumonia (RCP) and invasive pneumococcal disease (IPD) among young children in southern Mozambique.<br/><br/>Betuel Sigaúque, Leocádia Vilanculos, Alberto Chaúque, Benild Moiane, Hélio Mucavele, Sérgio Massora, Sozinho Acácio, Charfudin Sacoor, Llorenç Quintó, Benigna Matsinhe, Fabiana Pimenta, Cynthia G Whitney, Fernanda C Lessa, Maria da Glória Carvalho, Jennifer R Verani (2026) <i>Vaccine</i> <i></i> <i></i> 75: <br/>

//publicationslist.org/jrv/refid88 2026-04-01T22:24:49Z

Serotype-specific estimates of pneumococcal invasiveness used in pneumococcal carriage transmission models to predict changes in disease incidence post-vaccination are largely derived from high-income settings. We conducted a systematic review of carriage prevalence and invasive pneumococcal disease (IPD) incidence to calculate case-carrier ratios (CCRs) in different income settings.<br/><br/>Katherine E Gallagher, Fredrick Odiwour, Christian Bottomley, John Ojal, Aisha Adamu, Esther Muthumbi, Eunice W Kagucia, Laura L Hammitt, Sergio Massora, Betuel Sigaúque, Alberto Chaúque, Leocadia Vilanculos, Jennifer R Verani, Maria da Gloria Carvalho, Anne von Gottberg, Jackie Kleynhans, Shabir A Madhi, Courtney P Olwagen, Grant Mackenzie, Rasheed Salaudeen, Ryan Gierke, Miwako Kobayashi, Stephen Pelton, Inci Yildirim, Stepy Thomas, Amy Tunali, Monica Farley, Todd D Swarthout, Akuzike Kalizang'oma, Robert S Heyderman, Neil French, Yoon Choi, Nick Andrews, Shamez Ladhani, Elizabeth Miller, J Anthony G Scott (2026) <i>The Lancet. Microbe</i> <i></i> <i></i> 7: 3 <br/>

//publicationslist.org/jrv/refid110 2026-04-01T22:28:14Z

Antenatal care (ANC) is critical for optimizing the health of pregnant women and their newborns. The World Health Organization (WHO) initially recommended ≥4 ANC visits that was later revised in 2016 to ≥8 visits for adequate coverage. Adequate ANC utilization remains low in sub-Saharan Africa, including Kenya. We examined ANC coverage and timely initiation among pregnant women residing in Kib...<br/><br/>Alice Ouma, Clifford Oduor, George O Agogo, Robert Mutinda, Samwel Kiplangat, Florina Serbanescu, Patrick K Munywoki, Godfrey Bigogo, Jennifer R Verani (2026) <i>BMC pregnancy and childbirth</i> <i></i> <i></i> 26: 1 <br/>

//publicationslist.org/jrv/refid138 2026-04-01T22:45:05Z

In June 2021, Burkina Faso changed the 13-valent pneumococcal conjugate vaccine (PCV13) schedule from three primary doses with no booster (at 2, 3, 4 months) (3 + 0) to two primary doses with a booster (at 2, 4, 9 months) (2 + 1), which may optimize vaccine impact due to a booster dose.<br/><br/>Lana Childs, Robert Lamoussa Zoma, Issa Ouedraogo, Guetwendé Sawadogo, T Félix Tarbangdo, Aristide Zoma, Soumeya Ouangraoua, Emilie Dama, Theresa Tran, Fahmina Akhter, Simran Utreja, Mahamoudou Ouattara, Jennifer R Verani, Soufiane Sanou, H Flavien Aké, Lesley McGee, Miwako Kobayashi (2026) <i>Vaccine</i> <i></i> <i></i> 72: <br/>

//publicationslist.org/jrv/refid1 2026-04-01T22:15:11Z

Shigella is an important cause of diarrheal morbidity and mortality globally. Data on disease burden across age groups, in different epidemiologic settings, and over time are needed to guide preventive strategies. We examined shigellosis in two sites in Kenya over a 10-year period.<br/><br/>Richard Omore, Billy Ogwel, John B Ochieng, Jane Juma, Victor Omballa, Alice Ouma, George Aol, Allan Audi, George O Agogo, George Odongo, Clayton Onyango, Newton Wamola, Terry Komo, Daisy Chepkemoi, Elizabeth Hunsperger, Daniel R Feikin, Joel M Montgomery, Marc-Alain Widdowson, Graeme Prentice-Mott, Eric D Mintz, Robert F Breiman, Patrick K Munywoki, Godfrey M Bigogo, Jennifer R Verani (2026) <i>PloS one</i> <i></i> <i></i> 21: 3 <br/>

//publicationslist.org/jrv/refid54 2026-04-01T22:19:58Z

Seroprevalence studies can indicate the age-distribution of first infection with non-typhoidal Salmonella (NTS) and estimate the rate of infection by age.<br/><br/>Esther M Muthumbi, Sean C Elias, Alfred Mwanzu, Agnes Mutiso, Perpetual Wanjiku, Cecilia Mbae, Godfrey Bigogo, Jennifer R Verani, Stefan Flasche, Samuel Kariuki, Calman A MacLennan, J Anthony G Scott (2026) <i>The Journal of infectious diseases</i> <i></i> <i></i> : <br/>

//publicationslist.org/jrv/refid2 2026-04-01T22:15:11Z

Burkina Faso introduced 13-valent pneumococcal conjugate vaccine (PCV13) in 2013 and achieved >90% three-dose coverage. Recently, the Sahel Region has experienced a security crisis, resulting in decreasing PCV13 coverage. We examined pneumococcal carriage before a mass PCV13 campaign in the Sahel Region in 2022. In January and February 2022, we conducted a cross-sectional, age-stratified pneumococ...<br/><br/>Robert Lamoussa Zoma, Lana Childs, Issa Ouedraogo, Guetwendé Sawadogo, T Félix Tarbangdo, Aristide Zoma, Soufiane Sanou, Brice Bicaba, Simon Sanou, Fahmina Akhter, Mahamoudou Ouattara, Jennifer R Verani, Lesley McGee, Miwako Kobayashi, H Flavien Aké (2025) <i>The American journal of tropical medicine and hygiene</i> <i></i> <i></i> 113: 1 138-146<br/>

//publicationslist.org/jrv/refid89 2026-04-01T22:24:49Z

Use of 10-valent pneumococcal conjugate vaccine in Kenya has led to substantial reductions in vaccine-type pneumococcal carriage and invasive pneumococcal disease. However, analysis of recent surveillance data indicates an outbreak of vaccine-type serotype 1 in 2023 in Kibera, Kenya. Continued monitoring of invasive pneumococcal disease in Kenya is warranted.<br/><br/>Terry Komo, Patrick K Munywoki, Maria da Gloria Carvalho, Joshua Auko, Alice Ouma, Allan Audi, George O Agogo, Daniel Omondi, Arthur Odoyo, Herine Odiembo, Newton Wamola, Mike Osita, Clayton Onyango, Naomi Lucchi, Peninah Munyua, Amy Herman-Roloff, Shanda Larson, Sopio Chochua, Fabiana C Pimenta, Godfrey Bigogo, Jennifer R Verani (2025) <i>Emerging infectious diseases</i> <i></i> <i></i> 31: 2 345-349<br/>

//publicationslist.org/jrv/refid55 2026-04-01T22:19:58Z

Rebecca Kahn, Benild Moiane, Fernanda C Lessa, Sergio Massora, Viviana Mabombo, Alberto Chauque, Nelson Tembe, Helio Mucavele, Cynthia G Whitney, Charfudin Sacoor, Graca Matsinhe, Fabiana C Pimenta, Maria da Gloria Carvalho, Betuel Sigauque, Jennifer Verani (2025) <i>Vaccine</i> <i></i> <i></i> 56: <br/>

//publicationslist.org/jrv/refid111 2026-04-01T22:28:14Z

Widespread use of pneumococcal conjugate vaccines (PCVs) has reduced vaccine-type invasive pneumococcal disease (IPD). We describe the serotype distribution of IPD after extensive use of ten-valent PCV (PCV10; Synflorix, GSK) and 13-valent PCV (PCV13; Prevenar 13, Pfizer) globally.<br/><br/>Maria Garcia Quesada, Meagan E Peterson, Julia C Bennett, Kyla Hayford, Scott L Zeger, Yangyupei Yang, Marissa K Hetrich, Daniel R Feikin, Adam L Cohen, Anne von Gottberg, Mark van der Linden, Nina M van Sorge, Lucia H de Oliveira, Sara de Miguel, Inci Yildirim, Didrik F Vestrheim, Jennifer R Verani, Emmanuelle Varon, Palle Valentiner-Branth, Georgina Tzanakaki, Nadja Sinkovec Zorko, Lena P Setchanova, Fatima Serhan, Kevin J Scott, J Anthony Scott, Camelia Savulescu, Larisa Savrasova, Rita Reyburn, Kazunori Oishi, J Pekka Nuorti, Daniela Napoli, Jason M Mwenda, Carmen Muñoz-Almagro, Eva Morfeldt, Kimberley McMahon, Allison McGeer, Lucia Mad'arová, Grant A Mackenzie, Maria Eugenia León, Shamez N Ladhani, Karl G Kristinsson, Jana Kozakova, Jackie Kleynhans, Nicola P Klein, James D Kellner, Sanjay Jayasinghe, Pak-Leung Ho, Markus Hilty, Marcella A Harker-Jones, Laura L Hammitt, Marta Grgic-Vitek, Charlotte Gilkison, Ryan Gierke, Neil French, Idrissa Diawara, Stefanie Desmet, Philippe De Wals, Tine Dalby, Ron Dagan, Mary Corcoran, Edoardo Colzani, Grettel Chanto Chacón, Jesús Castilla, Romina Camilli, Michelle Ang, Krow Ampofo, Samanta C G Almeida, Pedro Alarcon, Katherine L O'Brien, Maria Deloria Knoll, (2025) <i>The Lancet. Infectious diseases</i> <i></i> <i></i> 25: 4 445-456<br/>

//publicationslist.org/jrv/refid3 2026-04-01T22:15:11Z

Mozambique introduced 10-valent-pneumococcal conjugate vaccine (PCV10) in 2013. We aimed to evaluate the indirect effect of PCV10 on invasive pneumococcal disease (IPD) and clinical severe pneumonia (CSP) in infants aged less than 10 weeks.<br/><br/>Sérgio Massora, Hélio Mucavele, Maria da Gloria Carvalho, Inácio Mandomando, Alberto Chaúque, Benild Moiane, Nelson Tembe, Saad B Omer, Quique Bassat, Jennifer R Verani, Clara Menéndez, Llorenç Quintó, Betuel Sigaúque, Azucena Bardají (2025) <i>The Pediatric infectious disease journal</i> <i></i> <i></i> 44: 2S S75-S79<br/>

//publicationslist.org/jrv/refid56 2026-04-01T22:19:58Z

Streptococcus pneumoniae is an important cause of pneumonia, sepsis, and meningitis, which are leading causes of child mortality. Pneumococcal conjugate vaccines (PCVs) protect against disease and nasopharyngeal colonization with vaccine serotypes, reducing transmission to and among unvaccinated individuals. Mozambique introduced 10-valent PCV (PCV10) in 2013. In 2017-2019, 13-valent PCV (PCV13) r...<br/><br/>Rebecca Kahn, Benild Moiane, Fernanda C Lessa, Sergio Massora, Viviana Mabombo, Alberto Chauque, Nelson Tembe, Helio Mucavele, Cynthia G Whitney, Charfudin Sacoor, Graca Matsinhe, Fabiana C Pimenta, Maria da Gloria Carvalho, Betuel Sigauque, Jennifer Verani (2025) <i>Vaccine</i> <i></i> <i></i> 47: <br/>

//publicationslist.org/jrv/refid127 2026-04-01T22:30:42Z

Campylobacteriosis and antimicrobial resistance (AMR) are global public health concerns. Africa is estimated to have the world's highest incidence of campylobacteriosis and a relatively high prevalence of AMR in Campylobacter spp. from humans and animals. Few studies have compared Campylobacter spp. isolated from humans and poultry in Africa using whole-genome sequencing and antimicrobial suscepti...<br/><br/>Nigel P French, Kate M Thomas, Nelson B Amani, Jackie Benschop, Godfrey M Bigogo, Sarah Cleaveland, Ahmed Fayaz, Ephrasia A Hugho, Esron D Karimuribo, Elizabeth Kasagama, Ruth Maganga, Matayo L Melubo, Anne C Midwinter, Blandina T Mmbaga, Victor V Mosha, Fadhili I Mshana, Peninah Munyua, John B Ochieng, Lynn Rogers, Emmanuel Sindiyo, Emanuel S Swai, Jennifer R Verani, Marc-Alain Widdowson, David A Wilkinson, Rudovick R Kazwala, John A Crump, Ruth N Zadoks (2024) <i>Emerging infectious diseases</i> <i></i> <i></i> 30: 10 2079-2089<br/>

//publicationslist.org/jrv/refid6 2026-04-01T22:15:40Z

A U.S. case-control study (2010-2014) demonstrated vaccine effectiveness (VE) for ≥ 1 dose of the thirteen-valent pneumococcal conjugate vaccine (PCV13) against vaccine-type (VT) invasive pneumococcal disease (IPD) at 86 %; however, it lacked statistical power to examine VE by number of doses and against individual serotypes.<br/><br/>Kristin L Andrejko, Ryan Gierke, Jemma V Rowlands, Jennifer B Rosen, Ann Thomas, Zachary Q Landis, Maria Rosales, Sue Petit, William Schaffner, Corinne Holtzman, Meghan Barnes, Monica M Farley, Lee H Harrison, Lesley McGee, Sopio Chochua, Jennifer R Verani, Adam L Cohen, Tamara Pilishvili, Miwako Kobayashi (2024) <i>Vaccine</i> <i></i> <i></i> 42: 16 3555-3563<br/>

//publicationslist.org/jrv/refid7 2026-04-01T22:16:00Z

In 2010, Brazil introduced the ten-valent pneumococcal conjugate vaccine (PCV10) in the national infant immunization program. Limited data on the long-term impact of PCV10 are available from lower-middle-income settings. We examined invasive pneumococcal disease (IPD) in Salvador, Bahia, over 11 years.<br/><br/>Joice Neves Reis, Jailton Azevedo, Aisla Mércia Lazaro de Oliveira, Ana Paula de Oliveira Menezes, Mayara Pedrosa, Milena Soares Dos Santos, Laise Carvalho Ribeiro, Humberto Fonseca de Freitas, Edilane Lins Gouveia, Marcelo Bastos Teles, Maria da Glória Carvalho, Mitermayer Galvão Reis, Cristiana Nascimento-Carvalho, Jennifer R Verani (2024) <i>Vaccine</i> <i></i> <i></i> 42: 3 591-597<br/>

//publicationslist.org/jrv/refid112 2026-04-01T22:28:14Z

Adverse birth outcomes particularly preterm births and congenital anomalies, are the leading causes of infant mortality globally, and the burden is highest in developing countries. We set out to determine the frequency of adverse birth outcomes and the risk factors associated with such outcomes in a cohort of pregnant women in Kenya.<br/><br/>Harriet Mirieri, Ruth Nduati, Jeanette Dawa, Lydia Okutoyi, Eric Osoro, Cyrus Mugo, Dalton Wamalwa, Hafsa Jin, Dufton Mwaengo, Nancy Otieno, Doris Marwanga, Mufida Shabibi, Peninah Munyua, John Kinuthia, Erin Clancey, Marc-Alain Widdowson, M Kariuki Njenga, Jennifer R Verani, Irene Inwani (2024) <i>BMC pregnancy and childbirth</i> <i></i> <i></i> 24: 1 <br/>

//publicationslist.org/jrv/refid90 2026-04-01T22:24:49Z

We examined the association between serum aflatoxin B1-lysine adduct (AFB1-lys) levels in pregnant women and adverse pregnancy outcomes (low birthweight, miscarriage and stillbirth) through a nested matched case-control study of pregnant women enroled at ≤28 weeks' gestation in Mombasa, Kenya, from 2017 to 2019. Cases comprised women with an adverse birth outcome, defined as either delivery of a...<br/><br/>Eric Osoro, Abigael O Awuor, Irene Inwani, Cyrus Mugo, Elizabeth Hunsperger, Jennifer R Verani, Ruth Nduati, John Kinuthia, Lydia Okutoyi, Dufton Mwaengo, Brian Maugo, Nancy A Otieno, Harriet Mirieri, Cynthia Ombok, Bryan Nyawanda, George O Agogo, Isaac Ngere, Nicholas C Zitomer, Michael E Rybak, Peninah Munyua, Kariuki Njenga, Marc-Alain Widdowson (2024) <i>Maternal & child nutrition</i> <i></i> <i></i> 20: 4 <br/>

//publicationslist.org/jrv/refid5 2026-04-01T22:15:40Z

Acute febrile illness (AFI) is a common reason for healthcare seeking and hospitalization in Sub-Saharan Africa and is often presumed to be malaria. However, a broad range of pathogens cause fever, and more comprehensive data on AFI etiology can improve clinical management, prevent unnecessary prescriptions, and guide public health interventions. We conducted surveillance for AFI (temperature ≥3...<br/><br/>Jennifer R Verani, Eric Ng' Eno, Elizabeth A Hunsperger, Peninah Munyua, Eric Osoro, Doris Marwanga, Godfrey Bigogo, Derrick Amon, Melvin Ochieng, Paul Etau, Victor Bandika, Victor Zimbulu, John Kiogora, John Wagacha Burton, Emmanuel Okunga, Aaron M Samuels, Kariuki Njenga, Joel M Montgomery, Marc-Alain Widdowson (2024) <i>PloS one</i> <i></i> <i></i> 19: 8 <br/>

//publicationslist.org/jrv/refid57 2026-04-01T22:19:58Z

Kenya introduced Synflorix™ (GlaxoSmithKline, PCV10-GSK), a 10-valent pneumococcal conjugate vaccine, in 2011, using three primary doses and, in select areas, catch-up campaigns. Surveys conducted 1-2 years post-introduction showed a stable prevalence of pneumococcal colonization, with declines in vaccine-type carriage. However, little is known about the long-term impact of PCV10-GSK in Kenya.<br/><br/>Jennifer R Verani, Daniel Omondi, Arthur Odoyo, Herine Odiembo, Alice Ouma, Juliet Ngambi, George Aol, Allan Audi, Samwel Kiplangat, Noel Agumba, Patrick K Munywoki, Clayton Onyango, Elizabeth Hunsperger, Jennifer L Farrar, Lindsay Kim, Miwako Kobayashi, Robert F Breiman, Fabiana C Pimenta, Maria da Gloria Carvalho, Fernanda C Lessa, Cynthia G Whitney, Godfrey Bigogo (2024) <i>Vaccine</i> <i></i> <i></i> 42: 25 <br/>

//publicationslist.org/jrv/refid4 2026-04-01T22:15:40Z

The role of meningitis in causing deaths and in children under 5 is unclear, especially since widespread use of vaccines to prevent common causes of meningitis. Child Health and Mortality Prevention Surveillance (CHAMPS) uses post-mortem minimally invasive tissue sampling (MITS) and ante-mortem data to explore death causes. We aimed to assess meningitis's contribution to mortality and identify cau...<br/><br/>Sana Mahtab, Zachary J Madewell, Vicky Baillie, Ziyaad Dangor, Sanjay G Lala, Nega Assefa, Mulu Berihun, Lola Madrid, Lemma Demissie Regassa, J Anthony G Scott, Soter Ameh, Joseph S Bangura, Okokon Ita, Erick Kaluma, Ikechukwu Udo Ogbuanu, Brigitte Gaume, Karen L Kotloff, Samba O Sow, Milagritos D Tapia, Sara Ajanovic, Marcelino Garrine, Inacio Mandomando, Rosauro Varo, Elisio G Xerinda, Muntasir Alam, Shams El Arifeen, Emily S Gurley, Mohammad Zahid Hossain, Afruna Rahman, Victor Akelo, Kitiezo Aggrey Igunza, Clayton Onyango, Dickens Onyango, Jennifer R Verani, Portia Mutevedzi, Cynthia G Whitney, Dianna M Blau, Shabir A Madhi, Quique Bassat, (2024) <i>The Journal of infection</i> <i></i> <i></i> 89: 6 <br/>

//publicationslist.org/jrv/refid58 2026-04-01T22:19:58Z

Shigellosis mainly affects children under 5 years of age living in low- and middle-income countries, who are the target population for vaccination. There are, however, limited data available to define the appropriate timing for vaccine administration in this age group. Information on antibody responses following natural infection, proxy for exposure, could help guide vaccination strategies.<br/><br/>Melissa C Kapulu, Esther Muthumbi, Edward Otieno, Omar Rossi, Pietro Ferruzzi, Francesca Necchi, Alessandra Acquaviva, Laura B Martin, Benedict Orindi, Kennedy Mwai, Hillary Kibet, Alfred Mwanzu, Godfrey M Bigogo, Jennifer R Verani, Cecilia Mbae, Christopher Nyundo, Charles N Agoti, Usman Nasir Nakakana, Valentino Conti, Philip Bejon, Samuel Kariuki, J Anthony G Scott, Francesca Micoli, Audino Podda (2024) <i>Frontiers in immunology</i> <i></i> <i></i> 15: <br/>

//publicationslist.org/jrv/refid12 2026-04-01T22:16:11Z

The magnitude of pediatric enteric pathogen exposures in low-income settings necessitates substantive water and sanitation interventions, including animal feces management. We assessed associations between pediatric enteric pathogen detection and survey-based water, sanitation, and animal characteristics within the Vaccine Impact on Diarrhea in Africa case-control study.<br/><br/>David M Berendes, Richard Omore, Graeme Prentice-Mott, Kirsten Fagerli, Sunkyung Kim, Dilruba Nasrin, Helen Powell, M Jahangir Hossain, Samba O Sow, Sanogo Doh, Joquina Chiquita M Jones, John B Ochieng, Jane Juma, Alex O Awuor, Billy Ogwel, Jennifer R Verani, Marc-Alain Widdowson, Irene N Kasumba, Sharon M Tennant, Anna Roose, Syed M A Zaman, Jie Liu, Ciara E Sugerman, James A Platts-Mills, Eric R Houpt, Karen L Kotloff, Eric D Mintz (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S140-S152<br/>

//publicationslist.org/jrv/refid11 2026-04-01T22:16:11Z

We evaluated the burden of Shigella spp from children aged 0-59 months with medically attended moderate-to-severe diarrhea and matched controls at sites in Mali, The Gambia, and Kenya participating in the Vaccine Impact on Diarrhea in Africa (VIDA) study from 2015 to 2018.<br/><br/>Irene N Kasumba, Henry Badji, Helen Powell, M Jahangir Hossain, Richard Omore, Samba O Sow, Jennifer R Verani, James A Platts-Mills, Marc-Alain Widdowson, Syed M A Zaman, Jennifer Jones, Sunil Sen, Jasnehta Permala-Booth, Shamima Nasrin, Anna Roose, Dilruba Nasrin, John Benjamin Ochieng, Jane Juma, Sanogo Doh, Joquina Chiquita M Jones, Martin Antonio, Alex O Awuor, Ciara E Sugerman, Nora Watson, Christopher Focht, Jie Liu, Eric Houpt, Karen L Kotloff, Sharon M Tennant (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S66-S76<br/>

//publicationslist.org/jrv/refid19 2026-04-01T22:16:20Z

The SARS-CoV-2 Omicron sublineage XBB was first detected in the United States in August 2022.* XBB together with a sublineage, XBB.1.5, accounted for >50% of sequenced lineages in the Northeast by December 31, 2022, and 52% of sequenced lineages nationwide as of January 21, 2023. COVID-19 vaccine effectiveness (VE) can vary by SARS-CoV-2 variant; reduced VE has been observed against some variants,...<br/><br/>Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, Heather M Scobie, Akilah R Ali, Joseph D Miller, Ryan E Wiegand, Emma K Accorsi, Jennifer R Verani, Nong Shang, Gordana Derado, Amadea Britton, Zachary R Smith, Katherine E Fleming-Dutra (2023) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 72: 5 119-124<br/>

//publicationslist.org/jrv/refid13 2026-04-01T22:16:11Z

Reducing diarrhea-related morbidity and mortality is a global priority, particularly in low-resource settings. We assessed adherence to diarrhea case management indicators in the Global Enteric Multisite Study (GEMS) and Vaccine Impact of Diarrhea in Africa (VIDA) study.<br/><br/>Emily L Deichsel, Adama Mamby Keita, Jennifer R Verani, Helen Powell, Leslie P Jamka, M Jahangir Hossain, Joquina Chiquita M Jones, Richard Omore, Alex O Awuor, Samba O Sow, Doh Sanogo, Milagritos D Tapia, Kathleen M Neuzil, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl 1 S23-S31<br/>

//publicationslist.org/jrv/refid10 2026-04-01T22:16:00Z

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.2/BA.2.12.1 and BA.4/BA.5 subvariants have mutations associated with increased capacity to evade immunity when compared with prior variants. We evaluated mRNA monovalent booster dose effectiveness among persons ≥5 years old during BA.2/BA.2.12.1 and BA.4/BA.5 predominance.<br/><br/>Allison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, Amadea Britton, Katherine E Fleming-Dutra, Joseph Miller, Emma K Accorsi, Jennifer R Verani, Nong Shang, Gordana Derado, Tamara Pilishvili, Ruth Link-Gelles (2023) <i>Open forum infectious diseases</i> <i></i> <i></i> 10: 5 <br/>

//publicationslist.org/jrv/refid15 2026-04-01T22:16:11Z

Diarrheal disease is heterogeneous, including watery diarrhea (WD) and dysentery, some cases of which become persistent diarrhea (PD). Changes in risk over time necessitate updated knowledge of these syndromes in sub-Saharan Africa.<br/><br/>Andrea G Buchwald, Jennifer R Verani, Adama Mamby Keita, M Jahangir Hossain, Anna Roose, Samba O Sow, Richard Omore, Sanogo Doh, Joquina Chiquita M Jones, Dilruba Nasrin, Syed M A Zaman, Catherine Okoi, Martin Antonio, John B Ochieng, Jane Juma, Uma Onwuchekwa, Helen Powell, James A Platts-Mills, Sharon M Tennant, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl 1 S12-S22<br/>

//publicationslist.org/jrv/refid92 2026-04-01T22:24:49Z

To address a paucity of data from sub-Saharan Africa, we examined the prevalence, severity, and seasonality of norovirus genogroup II (NVII) among children <5 years old in The Gambia, Kenya, and Mali following rotavirus vaccine introduction.<br/><br/>Richard Omore, Helen Powell, Samba O Sow, M Jahangir Hossain, Billy Ogwel, Sanogo Doh, John B Ochieng, Joquina Chiquita M Jones, Syed M A Zaman, Alex O Awuor, Jane Juma, Irene N Kasumba, Anna Roose, Leslie P Jamka, Dilruba Nasrin, Jie Liu, Adama Mamby Keita, Awa Traoré, Uma Onwuchekwa, Henry Badji, Golam Sarwar, Martin Antonio, Ciara E Sugerman, Eric D Mintz, Eric R Houpt, Jennifer R Verani, Marc-Alain Widdowson, Sharon M Tennant, James A Platts-Mills, Jacqueline E Tate, Umesh D Parashar, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S114-S122<br/>

//publicationslist.org/jrv/refid18 2026-04-01T22:16:20Z

Despite antibiotic prescription being recommended for dysentery and suspected cholera only, diarrhea still triggers unwarranted antibiotic prescription. We evaluated antibiotic-prescribing practices and their predictors among children aged 2-59 months in the Vaccine Impact on Diarrhea in Africa (VIDA) Study performed in The Gambia, Mali, and Kenya.<br/><br/>Alex O Awuor, Billy Ogwel, Helen Powell, Jennifer R Verani, Samba O Sow, M Jahangir Hossain, John B Ochieng, Jane Juma, Leslie P Jamka, Anna Roose, Sanogo Doh, Emily L Deichsel, Uma Onwuchekwa, Adama Mamby Keita, Martin Antonio, Joquina Chiquita M Jones, Syed M A Zaman, Henry Badji, Irene N Kasumba, Dilruba Nasrin, James A Platts-Mills, Eric R Houpt, David M Berendes, Ciara E Sugerman, Marc-Alain Widdowson, Sharon M Tennant, Eric D Mintz, Richard Omore, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S32-S40<br/>

//publicationslist.org/jrv/refid93 2026-04-01T22:24:49Z

Giardia has been associated with reduced risk of diarrhea in children in low-resource settings, but the mechanism underlying this association is unknown. To assess whether Giardia may shape colonization or infection with other enteric pathogens and impact associations with diarrhea, we examined Giardia and enteric pathogen codetection among children <5 years old in Kenya, The Gambia, and Mali as p...<br/><br/>Perrine Marcenac, Awa Traoré, Sunkyung Kim, Graeme Prentice-Mott, David M Berendes, Helen Powell, Irene N Kasumba, Dilruba Nasrin, Joquina Chiquita M Jones, Syed M A Zaman, John B Ochieng, Jane Juma, Doh Sanogo, Marc-Alain Widdowson, Jennifer R Verani, Jie Liu, Eric R Houpt, M Jahangir Hossain, Samba O Sow, Richard Omore, Sharon M Tennant, Eric D Mintz, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S106-S113<br/>

//publicationslist.org/jrv/refid17 2026-04-01T22:16:20Z

Stunting affects >20% of children <5 years old worldwide and disproportionately impacts underserved communities. The Vaccine Impact on Diarrhea in Africa (VIDA) Study examined the association between an episode of moderate-to-severe diarrhea (MSD) and the risk of subsequent stunting in children <5 years living in 3 sub-Saharan African countries.<br/><br/>Dilruba Nasrin, Yuanyuan Liang, Helen Powell, Ines Gonzalez Casanova, Samba O Sow, M Jahangir Hossain, Richard Omore, Doh Sanogo, Boubou Tamboura, Syed M A Zaman, Martin Antonio, Joquina Chiquita M Jones, Alex O Awuor, Irene N Kasumba, John B Ochieng, Henry Badji, Jennifer R Verani, Marc-Alain Widdowson, Anna Roose, Leslie P Jamka, Sharon M Tennant, Usha Ramakrishnan, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S41-S48<br/>

//publicationslist.org/jrv/refid9 2026-04-01T22:16:00Z

Reliable mortality data are important for evaluating the impact of health interventions. However, data on mortality patterns among populations living in urban informal settlements are limited.<br/><br/>Clifford Oduor, Irene Omwenga, Alice Ouma, Robert Mutinda, Samwel Kiplangat, Ondari D Mogeni, Leonard Cosmas, Allan Audi, George S Odongo, David Obor, Robert Breiman, Joel Montgomery, George Agogo, Patrick Munywoki, Godfrey Bigogo, Jennifer R Verani (2023) <i>Global health action</i> <i></i> <i></i> 16: 1 <br/>

//publicationslist.org/jrv/refid16 2026-04-01T22:16:20Z

To address knowledge gaps regarding diarrheagenic Escherichia coli (DEC) in Africa, we assessed the clinical and epidemiological features of enteroaggregative E. coli (EAEC), enteropathogenic E. coli (EPEC), and Shiga toxin-producing E. coli (STEC) positive children with moderate-to-severe diarrhea (MSD) in Mali, The Gambia, and Kenya.<br/><br/>John B Ochieng, Helen Powell, Ciara E Sugerman, Richard Omore, Billy Ogwel, Jane Juma, Alex O Awuor, Samba O Sow, Doh Sanogo, Uma Onwuchekwa, Adama Mamby Keita, Awa Traoré, Henry Badji, M Jahangir Hossain, Joquina Chiquita M Jones, Irene N Kasumba, Dilruba Nasrin, Anna Roose, Yuanyuan Liang, Leslie P Jamka, Martin Antonio, James A Platts-Mills, Jie Liu, Eric R Houpt, Eric D Mintz, Elizabeth Hunsperger, Clayton O Onyango, Nancy Strockbine, Marc-Alain Widdowson, Jennifer R Verani, Sharon M Tennant, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S77-S86<br/>

//publicationslist.org/jrv/refid14 2026-04-01T22:16:11Z

Pediatric exposures to unsafe sources of water, unsafely managed sanitation, and animals are prevalent in low- and middle-income countries. In the Vaccine Impact on Diarrhea in Africa case-control study, we examined associations between these risk factors and moderate-to-severe diarrhea (MSD) in children <5 years old in The Gambia, Kenya, and Mali.<br/><br/>David M Berendes, Kirsten Fagerli, Sunkyung Kim, Dilruba Nasrin, Helen Powell, Irene N Kasumba, Sharon M Tennant, Anna Roose, M Jahangir Hossain, Joquina Chiquita M Jones, Syed M A Zaman, Richard Omore, John B Ochieng, Jennifer R Verani, Marc-Alain Widdowson, Samba O Sow, Sanogo Doh, Ciara E Sugerman, Eric D Mintz, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S132-S139<br/>

//publicationslist.org/jrv/refid114 2026-04-01T22:28:14Z

We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period.<br/><br/>Nicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, Melissa S Stockwell, Anupam B Kharbanda, Manjusha Gaglani, Suchitra Rao, Ned Lewis, Stephanie A Irving, Emily Hartmann, Karthik Natarajan, Alexandra F Dalton, Ousseny Zerbo, Malini B DeSilva, Deepika Konatham, Edward Stenehjem, Elizabeth A K Rowley, Toan C Ong, Shaun J Grannis, Chantel Sloan-Aagard, Jungmi Han, Jennifer R Verani, Chandni Raiyani, Kristin Dascomb, Sarah E Reese, Michelle A Barron, William F Fadel, Allison L Naleway, Juan Nanez, Monica Dickerson, Kristin Goddard, Kempapura Murthy, Nancy Grisel, Zacharay A Weber, Brian E Dixon, Palak Patel, Bruce Fireman, Julie Arndorfer, Nimish R Valvi, Eric P Griggs, Carly Hallowell, Peter J Embi, Sarah W Ball, Mark G Thompson, Mark W Tenforde, Ruth Link-Gelles (2023) <i>Pediatrics</i> <i></i> <i></i> 151: 5 <br/>

//publicationslist.org/jrv/refid128 2026-04-01T22:30:42Z

Studies conducted before rotavirus vaccine introduction found that moderate-to-severe diarrhea (MSD) in children aged <5 years was associated with stunting at follow-up. It is unknown whether the reduction in rotavirus-associated MSD following vaccine introduction decreased the risk of stunting.<br/><br/>Dilruba Nasrin, Yuanyuan Liang, Jennifer R Verani, Helen Powell, Samba O Sow, Richard Omore, M Jahangir Hossain, Sanogo Doh, Syed M A Zaman, Joquina Chiquita M Jones, Alex O Awuor, Irene N Kasumba, Sharon M Tennant, Usha Ramakrishnan, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S49-S57<br/>

//publicationslist.org/jrv/refid8 2026-04-01T22:16:00Z

Despite the importance of non-Typhoidal Salmonella (NTS) disease in Africa, epidemiologic data on carriage and transmission are few. These data are important to understand the transmission of NTS in Africa and to design control strategies.<br/><br/>Esther M Muthumbi, Alfred Mwanzu, Cecilia Mbae, Godfrey Bigogo, Angela Karani, Salim Mwarumba, Jennifer R Verani, Samuel Kariuki, J Anthony G Scott (2023) <i>PLoS neglected tropical diseases</i> <i></i> <i></i> 17: 10 <br/>

//publicationslist.org/jrv/refid113 2026-04-01T22:28:14Z

Despite the disproportionate morbidity and mortality experienced by American Indian and Alaska Native (AI/AN) persons during the coronavirus disease 2019 (COVID-19) pandemic, few studies have reported vaccine effectiveness (VE) estimates among these communities.<br/><br/>Chelsea S Lutz, Rachel M Hartman, Deionna E Vigil, Amadea Britton, Amanda B Burrage, Angela P Campbell, Ryan M Close, Christine Desnoyers, Jennifer Dobson, Starla Garcia, Natasha Halasa, Elvira Honie, Miwako Kobayashi, Meredith McMorrow, Heba H Mostafa, Dennie Parker, Kyle Pohl, Mila M Prill, Jennifer Richards, Kristen C Roessler, Catherine G Sutcliffe, Kim Taylor, Amy Swango-Wilson, Puthiery Va, Jennifer R Verani, Rosalyn J Singleton, Laura L Hammitt (2023) <i>Open forum infectious diseases</i> <i></i> <i></i> 10: 4 <br/>

//publicationslist.org/jrv/refid62 2026-04-01T22:20:13Z

While rotavirus causes severe diarrheal disease in children aged <5 years, data on other viral causes in sub-Saharan Africa are limited.<br/><br/>Adama Mamby Keita, Sanogo Doh, Samba O Sow, Helen Powell, Richard Omore, M Jahangir Hossain, Billy Ogwel, John B Ochieng, Joquina Chiquita M Jones, Syed M A Zaman, Alex O Awuor, Jane Juma, Dilruba Nasrin, Jie Liu, Awa Traoré, Uma Onwuchekwa, Henry Badji, Golam Sarwar, Martin Antonio, Eric R Houpt, Sharon M Tennant, Irene N Kasumba, Leslie P Jamka, Anna Roose, James A Platts-Mills, Jennifer R Verani, Jacqueline E Tate, Umesh D Parashar, Kathleen M Neuzil, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S123-S131<br/>

//publicationslist.org/jrv/refid63 2026-04-01T22:20:13Z

Previously studied risk factors for rotavirus vaccine failure have not fully explained reduced rotavirus vaccine effectiveness in low-income settings. We assessed the relationship between histo-blood group antigen (HBGA) phenotypes and clinical rotavirus vaccine failure among children <2 years of age participating in the Vaccine Impact on Diarrhea in Africa Study in 3 sub-Saharan African countries...<br/><br/>Lauren M Schwartz, Jennifer Oshinsky, Mardi Reymann, Mathew D Esona, Michael D Bowen, M Jahangir Hossain, Syed M A Zaman, Joquina Chiquita M Jones, Martin Antonio, Henry Badji, Golam Sarwar, Samba O Sow, Doh Sanogo, Adama Mamby Keita, Boubou Tamboura, Awa Traoré, Uma Onwuchekwa, Richard Omore, Jennifer R Verani, Alex O Awuor, John B Ochieng, Jane Juma, Billy Ogwel, Umesh D Parashar, Jacqueline E Tate, Irene N Kasumba, Sharon M Tennant, Kathleen M Neuzil, Ali Rowhani-Rahbar, M Elizabeth Halloran, Robert L Atmar, Marcela F Pasetti, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S153-S161<br/>

//publicationslist.org/jrv/refid64 2026-04-01T22:20:13Z

Non-typhoidal Salmonella (NTS) is a common cause of gastroenteritis in young children, with limited data on NTS serovars and antimicrobial resistance in Africa.<br/><br/>Irene N Kasumba, Helen Powell, Richard Omore, M Jahangir Hossain, Samba O Sow, John Benjamin Ochieng, Henry Badji, Jennifer R Verani, Marc-Alain Widdowson, Sunil Sen, Shamima Nasrin, Jasnehta Permala-Booth, Jennifer A Jones, Anna Roose, Dilruba Nasrin, Ciara E Sugerman, Jane Juma, Alex Awuor, Joquina Chiquita M Jones, Sanogo Doh, Catherine Okoi, Syed M A Zaman, Martin Antonio, Elizabeth Hunsperger, Clayton Onyango, James Platts-Mills, Jie Liu, Eric Houpt, Kathleen M Neuzil, Karen L Kotloff, Sharon M Tennant (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S87-S96<br/>

//publicationslist.org/jrv/refid59 2026-04-01T22:20:13Z

Invasive Group B (GBS) is a common cause of early-onset neonatal sepsis and is also associated with stillbirth. This study aimed to determine the proportion of stillborn infants and infants who died between 0 and 90 days attributable to GBS using postmortem minimally invasive tissue sampling (MITS) in 7 low- and middle-income countries (LMICs) participating in Child Health and Mortality Preventio...<br/><br/>Sana Mahtab, Zachary J Madewell, Shabir A Madhi, Amy Wise, Peter J Swart, Sithembiso Velaphi, Inacio Mandomando, Justina Bramugy, Rita Mabunda, Elisio Xerinda, Anthony G Scott, Nega Assefa, Lola Madrid, Mulu Bweihun, Fikremelekot Temesgen, Dickens Onyango, Victor Akelo, Richard Oliech, Peter Otieno, Jennifer R Verani, Shams El Arifeen, Emily S Gurley, Muntasir Alam, Afruna Rahman, Mohammad Zahid Hossain, Samba Sow, Karen Kotloff, Milagritos Tapia, Adama Mamby Keita, Doh Sanogo, Ikechukwu Ogbuanu, Julius Ojulong, Sandra Lako, Okokon Ita, Erick Kaluma, Tais Wilson, Portia Mutevedzi, Beth A Tippett Barr, Cynthia G Whitney, Dianna M Blau, Quique Bassat, (2023) <i>Open forum infectious diseases</i> <i></i> <i></i> 10: 9 <br/>

//publicationslist.org/jrv/refid139 2026-04-01T22:45:05Z

On June 18, 2022, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for use of the 2-dose monovalent Moderna COVID-19 vaccine as a primary series for children aged 6 months-5 years* and the 3-dose monovalent Pfizer-BioNTech COVID-19 vaccine as a primary series for children aged 6 months-4 years, based on safety, immunobridging, and limited efficacy data from cl...<br/><br/>Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, Zachary R Smith, Joseph D Miller, Emma K Accorsi, Jennifer R Verani, Nong Shang, Gordana Derado, Ryan E Wiegand, Tamara Pilishvili, Amadea Britton, Ruth Link-Gelles (2023) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 72: 7 177-182<br/>

//publicationslist.org/jrv/refid60 2026-04-01T22:20:13Z

Typhoid fever burden can vary over time. Long-term data can inform prevention strategies; however, such data are lacking in many African settings. We reexamined typhoid fever incidence and antimicrobial resistance (AMR) over a 10-year period in Kibera, a densely populated urban informal settlement where a high burden has been previously described. We used data from the Population Based Infectious ...<br/><br/>Eric Ng'eno, Margaret Lind, Allan Audi, Alice Ouma, Clifford Oduor, Patrick K Munywoki, George O Agogo, George Odongo, Samuel Kiplangat, Newton Wamola, Mike Powel Osita, Robert Mugoh, Caroline Ochieng, Victor Omballa, Ondari D Mogeni, Matthew Mikoleit, Barry S Fields, Joel M Montgomery, Jillian Gauld, Robert F Breiman, Bonventure Juma, Elizabeth Hunsperger, Marc-Alain Widdowson, Godfrey Bigogo, Eric D Mintz, Jennifer R Verani (2023) <i>The American journal of tropical medicine and hygiene</i> <i></i> <i></i> 109: 1 22-31<br/>

//publicationslist.org/jrv/refid61 2026-04-01T22:20:13Z

As part of the Vaccine Impact on Diarrhea in Africa (VIDA) Study, we examined the prevalence, clinical presentation, and seasonality of Cryptosporidium in children to understand its relative burden after the introduction of rotavirus vaccine.<br/><br/>M Jahangir Hossain, Helen Powell, Samba O Sow, Richard Omore, Anna Roose, Joquina Chiquita M Jones, Syed M A Zaman, Henry Badji, Golam Sarwar, Irene N Kasumba, Uma Onwuchekwa, Sanogo Doh, Alex O Awuor, John B Ochieng, Jennifer R Verani, Jie Liu, Sharon M Tennant, Dilruba Nasrin, Leslie P Jamka, Yuanyuan Liang, Stephen R C Howie, Martin Antonio, Eric R Houpt, Karen L Kotloff (2023) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 76: 76 Suppl1 S97-S105<br/>

//publicationslist.org/jrv/refid22 2026-04-01T22:16:31Z

This study evaluated messages and communication approaches for maternal immunization uptake in Kenya. We identified persuasive communication aspects that would inform maternal immunization attitudes, intent, and vaccine uptake.<br/><br/>Paula M Frew, Ines Gonzalez-Casanova, Nancy A Otieno, Fauzia A Malik, Vincent L Fenimore, Dominique Owino, Maxwell O Adero, Raphael O Atito, Godfrey Bigogod, Sandra S Chaves, Jennifer R Verani, Marc Alain Widdowson, Saad B Omer (2022) <i>Vaccine</i> <i></i> <i></i> 40: 27 3761-3770<br/>

//publicationslist.org/jrv/refid23 2026-04-01T22:16:42Z

The impact of human immunodeficiency virus (HIV) on pregnancy outcomes for women on antiretroviral therapy (ART) in sub-Saharan Africa remains unclear.<br/><br/>Cyrus Mugo, Ruth Nduati, Eric Osoro, Bryan O Nyawanda, Harriet Mirieri, Elizabeth Hunsperger, Jennifer R Verani, Hafsa Jin, Dufton Mwaengo, Brian Maugo, James Machoki, Nancy A Otieno, Cynthia Ombok, Mufida Shabibi, Lydia Okutoyi, John Kinuthia, Marc Alain Widdowson, Kariuki Njenga, Irene Inwani, Dalton Wamalwa (2022) <i>The Journal of infectious diseases</i> <i></i> <i></i> 226: 4 678-686<br/>

//publicationslist.org/jrv/refid24 2026-04-01T22:16:42Z

CDC recommends that all persons aged ≥18 years receive a single COVID-19 vaccine booster dose ≥2 months after receipt of an Ad.26.COV2.S (Janssen [Johnson & Johnson]) adenovirus vector-based primary series vaccine; a heterologous COVID-19 mRNA vaccine is preferred over a homologous (matching) Janssen vaccine for booster vaccination. This recommendation was made in light of the risks for rare b...<br/><br/>Karthik Natarajan, Namrata Prasad, Kristin Dascomb, Stephanie A Irving, Duck-Hye Yang, Manjusha Gaglani, Nicola P Klein, Malini B DeSilva, Toan C Ong, Shaun J Grannis, Edward Stenehjem, Ruth Link-Gelles, Elizabeth A Rowley, Allison L Naleway, Jungmi Han, Chandni Raiyani, Gabriela Vazquez Benitez, Suchitra Rao, Ned Lewis, William F Fadel, Nancy Grisel, Eric P Griggs, Margaret M Dunne, Melissa S Stockwell, Mufaddal Mamawala, Charlene McEvoy, Michelle A Barron, Kristin Goddard, Nimish R Valvi, Julie Arndorfer, Palak Patel, Patrick K Mitchell, Michael Smith, Anupam B Kharbanda, Bruce Fireman, Peter J Embi, Monica Dickerson, Jonathan M Davis, Ousseny Zerbo, Alexandra F Dalton, Mehiret H Wondimu, Eduardo Azziz-Baumgartner, Catherine H Bozio, Sue Reynolds, Jill Ferdinands, Jeremiah Williams, Stephanie J Schrag, Jennifer R Verani, Sarah Ball, Mark G Thompson, Brian E Dixon (2022) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 71: 13 495-502<br/>

//publicationslist.org/jrv/refid30 2026-04-01T22:17:24Z

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination coverage increases in the United States, there is a need to understand the real-world effectiveness against severe coronavirus disease 2019 (COVID-19) and among people at increased risk for poor outcomes.<br/><br/>Mark W Tenforde, Manish M Patel, Adit A Ginde, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Matthew C Exline, Michelle N Gong, Amira Mohamed, Daniel J Henning, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Caitlin C Ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Alexandra June Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Hayley B Gershengorn, Hilary M Babcock, Jennie H Kwon, Natasha Halasa, James D Chappell, Adam S Lauring, Carlos G Grijalva, Todd W Rice, Ian D Jones, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Samantha M Olson, Meagan Stephenson, Stephanie J Schrag, Miwako Kobayashi, Jennifer R Verani, Wesley H Self, (2022) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 74: 9 1515-1524<br/>

//publicationslist.org/jrv/refid66 2026-04-01T22:20:25Z

Zika virus (ZIKV), first discovered in Uganda in 1947, re-emerged globally in 2013 and was later associated with microcephaly and other birth defects. We determined the incidence of ZIKV infection and its association with adverse pregnancy and fetal outcomes in a pregnancy cohort in Kenya.<br/><br/>Eric Osoro, Irene Inwani, Cyrus Mugo, Elizabeth Hunsperger, Jennifer R Verani, Victor Omballa, Dalton Wamalwa, Chulwoo Rhee, Ruth Nduati, John Kinuthia, Hafsa Jin, Lydia Okutoyi, Dufton Mwaengo, Brian Maugo, Nancy A Otieno, Harriet Mirieri, Mufida Shabibi, Peninah Munyua, M Kariuki Njenga, Marc-Alain Widdowson (2022) <i>BMC medicine</i> <i></i> <i></i> 20: 1 <br/>

//publicationslist.org/jrv/refid67 2026-04-01T22:20:25Z

Antimicrobial stewardship encourages appropriate antibiotic use, the specific activities of which will vary by institutional context. We investigated regional variation in antibiotic use by surveying three regional public hospitals in Kenya. Hospital-level data for antimicrobial stewardship activities, infection prevention and control, and laboratory diagnostic capacities were collected from hospi...<br/><br/>Sylvia Omulo, Margaret Oluka, Loice Achieng, Eric Osoro, Rosaline Kinuthia, Anastasia Guantai, Sylvia Adisa Opanga, Marion Ongayo, Linus Ndegwa, Jennifer R Verani, Eveline Wesangula, Jarred Nyakiba, Jones Makori, Wilson Sugut, Charles Kwobah, Hanako Osuka, M Kariuki Njenga, Douglas R Call, Guy H Palmer, Daniel VanderEnde, Ulzii-Orshikh Luvsansharav (2022) <i>PloS one</i> <i></i> <i></i> 17: 6 <br/>

//publicationslist.org/jrv/refid68 2026-04-01T22:20:25Z

Efficacy of 2 doses of the BNT162b2 COVID-19 vaccine (Pfizer-BioNTech) against COVID-19 was high in pediatric trials conducted before the SARS-CoV-2 Omicron variant emerged. Among adults, estimated vaccine effectiveness (VE) of 2 BNT162b2 doses against symptomatic Omicron infection was reduced compared with prior variants, waned rapidly, and increased with a booster.<br/><br/>Katherine E Fleming-Dutra, Amadea Britton, Nong Shang, Gordana Derado, Ruth Link-Gelles, Emma K Accorsi, Zachary R Smith, Joseph Miller, Jennifer R Verani, Stephanie J Schrag (2022) <i>JAMA</i> <i></i> <i></i> 327: 22 2210-2219<br/>

//publicationslist.org/jrv/refid21 2026-04-01T22:16:31Z

In April 2021, we assessed mRNA vaccine effectiveness (VE) in the context of a COVID-19 outbreak in a skilled nursing facility. Among 28 cases, genomic sequencing was performed on 4 specimens on 4 different patients, and all were classified by sequence analysis as the Beta (B.1.351) variant. Adjusted VE among residents was 65% (95% confidence interval: 25-84%). These findings underscore the import...<br/><br/>Heidi L Moline, Amelia Keaton, Whitney Rice, Jasmine Varghese, Li Deng, Ansley Waters, Anna Barringer, Devonne Winston, Virgie Fields, Kara Jacobs Slifka, Jennifer R Verani, Stephanie J Schrag, John Jernigan, Jacqueline E Tate, Katherine E Fleming-Dutra (2022) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 75: Suppl 2 S155-S158<br/>

//publicationslist.org/jrv/refid65 2026-04-01T22:20:25Z

We estimated the prevalence of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE), carbapenem-resistant Enterobacterales (CRE), and methicillin-resistant Staphylococcus aureus (MRSA) in communities and hospitals in Kenya to identify human colonization with multidrug-resistant bacteria. Nasal and fecal specimen were collected from inpatients and community residents in Nairobi (urban...<br/><br/>Teresa Ita, Ulzii-Orshikh Luvsansharav, Rachel M Smith, Robert Mugoh, Charchil Ayodo, Beatrice Oduor, Moureen Jepleting, Walter Oguta, Caroline Ouma, Jane Juma, Godfrey Bigogo, Samuel Kariuki, Brooke M Ramay, Mark Caudell, Clayton Onyango, Linus Ndegwa, Jennifer R Verani, Susan Bollinger, Aditya Sharma, Guy H Palmer, Douglas R Call, Sylvia Omulo (2022) <i>Scientific reports</i> <i></i> <i></i> 12: 1 <br/>

//publicationslist.org/jrv/refid69 2026-04-01T22:20:25Z

The study objective was to evaluate 2- and 3-dose coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among adult solid organ transplant (SOT) recipients.<br/><br/>Jennie H Kwon, Mark W Tenforde, Manjusha Gaglani, H Keipp Talbot, Adit A Ginde, Tresa McNeal, Shekhar Ghamande, David J Douin, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Sean D Caspers, Matthew C Exline, Mena Botros, Michelle N Gong, Alex Li, Amira Mohamed, Nicholas J Johnson, Vasisht Srinivasan, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Akram Khan, Catherine L Hough, Laurence W Busse, Abhijit Duggal, Jennifer G Wilson, Cynthia Perez, Steven Y Chang, Christopher Mallow, Randal Rovinski, Hilary M Babcock, Adam S Lauring, Laura Felley, Natasha Halasa, James D Chappell, Carlos G Grijalva, Todd W Rice, Kelsey N Womack, Christopher J Lindsell, Kimberly W Hart, Adrienne Baughman, Samantha M Olson, Stephanie Schrag, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, Wesley H Self (2022) <i>The Journal of infectious diseases</i> <i></i> <i></i> 226: 5 797-807<br/>

//publicationslist.org/jrv/refid26 2026-04-01T22:16:57Z

Peter J Embi, Matthew E Levy, Allison L Naleway, Palak Patel, Manjusha Gaglani, Karthik Natarajan, Kristin Dascomb, Toan C Ong, Nicola P Klein, I-Chia Liao, Shaun J Grannis, Jungmi Han, Edward Stenehjem, Margaret M Dunne, Ned Lewis, Stephanie A Irving, Suchitra Rao, Charlene McEvoy, Catherine H Bozio, Kempapura Murthy, Brian E Dixon, Nancy Grisel, Duck-Hye Yang, Kristin Goddard, Anupam B Kharbanda, Sue Reynolds, Chandni Raiyani, William F Fadel, Julie Arndorfer, Elizabeth A Rowley, Bruce Fireman, Jill Ferdinands, Nimish R Valvi, Sarah W Ball, Ousseny Zerbo, Eric P Griggs, Patrick K Mitchell, Rachael M Porter, Salome A Kiduko, Lenee Blanton, Yan Zhuang, Andrea Steffens, Sarah E Reese, Natalie Olson, Jeremiah Williams, Monica Dickerson, Meredith McMorrow, Stephanie J Schrag, Jennifer R Verani, Alicia M Fry, Eduardo Azziz-Baumgartner, Michelle A Barron, Mark G Thompson, Malini B DeSilva (2022) <i>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</i> <i></i> <i></i> 22: 1 306-314<br/>

//publicationslist.org/jrv/refid71 2026-04-01T22:20:38Z

Vaccine effectiveness (VE) against COVID-19 hospitalization was evaluated among immunocompetent adults (≥18 years) during March-August 2021 using a case-control design. Among 1669 hospitalized COVID-19 cases (11% fully vaccinated) and 1950 RT-PCR-negative controls (54% fully vaccinated), VE was 96% (95% confidence interval [CI], 93%-98%) among patients with no chronic medical conditions and 83% ...<br/><br/>Nathaniel M Lewis, Eric A Naioti, Wesley H Self, Adit A Ginde, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Manjusha Gaglani, Shekhar A Ghamande, Tresa A McNeal, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Michelle N Gong, Amira Mohamed, Daniel J Henning, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Kinsley Hubel, Catherine L Hough, Laurence W Busse, Caitlin C Ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Alexandra J Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Matthew C Exline, Natasha Halasa, James D Chappell, Adam S Lauring, Carlos G Grijalva, Todd W Rice, Jillian P Rhoads, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Stephanie J Schrag, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, Mark W Tenforde, (2022) <i>The Journal of infectious diseases</i> <i></i> <i></i> 225: 10 1694-1700<br/>

//publicationslist.org/jrv/refid70 2026-04-01T22:20:25Z

Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.<br/><br/>Emma K Accorsi, Amadea Britton, Katherine E Fleming-Dutra, Zachary R Smith, Nong Shang, Gordana Derado, Joseph Miller, Stephanie J Schrag, Jennifer R Verani (2022) <i>JAMA</i> <i></i> <i></i> 327: 7 639-651<br/>

//publicationslist.org/jrv/refid25 2026-04-01T22:16:57Z

Recent studies have provided key information about SARS-CoV-2 vaccines' efficacy and effectiveness (VE). One important question that remains is whether the protection conferred by vaccines wanes over time. However, estimates over time are subject to bias from differential depletion of susceptible individuals between vaccinated and unvaccinated groups. We examined the extent to which biases occur u...<br/><br/>Rebecca Kahn, Stephanie J Schrag, Jennifer R Verani, Marc Lipsitch (2022) <i>American journal of epidemiology</i> <i></i> <i></i> 191: 5 800-811<br/>

//publicationslist.org/jrv/refid97 2026-04-01T22:25:07Z

To characterize the clinical severity of covid-19 associated with the alpha, delta, and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the effectiveness of mRNA vaccines to prevent hospital admissions related to each variant.<br/><br/>Adam S Lauring, Mark W Tenforde, James D Chappell, Manjusha Gaglani, Adit A Ginde, Tresa McNeal, Shekhar Ghamande, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Matthew C Exline, Michelle N Gong, Amira Mohamed, Nicholas J Johnson, Vasisht Srinivasan, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Caitlin C Ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Alexandra June Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Natasha Halasa, Carlos G Grijalva, Todd W Rice, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Jillian P Rhoads, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Katherine Adams, Stephanie J Schrag, Samantha M Olson, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, Wesley H Self, (2022) <i>BMJ (Clinical research ed.)</i> <i></i> <i></i> 376: <br/>

//publicationslist.org/jrv/refid115 2026-04-01T22:28:14Z

Emma K Accorsi, Amadea Britton, Nong Shang, Katherine E Fleming-Dutra, Ruth Link-Gelles, Zachary R Smith, Gordana Derado, Joseph Miller, Stephanie J Schrag, Jennifer R Verani (2022) <i>The New England journal of medicine</i> <i></i> <i></i> 386: 25 2433-2435<br/>

//publicationslist.org/jrv/refid20 2026-04-01T22:16:31Z

Pregnant people are at high risk for severe COVID-19 but were excluded from mRNA vaccine trials; data on COVID-19 vaccine effectiveness (VE) are needed.<br/><br/>Stephanie J Schrag, Jennifer R Verani, Brian E Dixon, Jessica M Page, Kristen A Butterfield, Manjusha Gaglani, Gabriela Vazquez-Benitez, Ousseny Zerbo, Karthik Natarajan, Toan C Ong, Victoria Lazariu, Suchitra Rao, Ryan Beaver, Sascha R Ellington, Nicola P Klein, Stephanie A Irving, Shaun J Grannis, Salome Kiduko, Michelle A Barron, John Midturi, Monica Dickerson, Ned Lewis, Melissa S Stockwell, Edward Stenehjem, William F Fadel, Ruth Link-Gelles, Kempapura Murthy, Kristin Goddard, Nancy Grisel, Nimish R Valvi, Bruce Fireman, Julie Arndorfer, Deepika Konatham, Sarah Ball, Mark G Thompson, Allison L Naleway (2022) <i>JAMA network open</i> <i></i> <i></i> 5: 9 <br/>

//publicationslist.org/jrv/refid129 2026-04-01T22:30:42Z

Maternal immunisation to boost respiratory syncytial virus (RSV) antibodies in pregnant women, is a strategy being considered to enhance infant protection from severe RSV associated disease. However, little is known about the efficiency of transplacental transfer of RSV-specific antibodies in a setting with a high burden of malaria and HIV, to guide the implementation of such a vaccination program...<br/><br/>Joyce U Nyiro, Elizabeth Bukusi, Dufton Mwaengo, Amek Nyaguara, Bryan Nyawanda, Nancy Otieno, Godfrey Bigogo, Nickson Murunga, Marc-Alain Widdowson, Jennifer R Verani, Sandra S Chaves, Hope Mwangudza, Calleb Odundo, James A Berkley, D James Nokes, Patrick K Munywoki (2022) <i>Wellcome open research</i> <i></i> <i></i> 7: <br/>

//publicationslist.org/jrv/refid98 2026-04-01T22:25:07Z

In the USA, COVID-19 vaccines became available in mid-December, 2020, with adults aged 65 years and older among the first groups prioritised for vaccination. We estimated the national-level impact of the initial phases of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older.<br/><br/>Lucy A McNamara, Ryan E Wiegand, Rachel M Burke, Andrea J Sharma, Michael Sheppard, Jennifer Adjemian, Farida B Ahmad, Robert N Anderson, Kamil E Barbour, Alison M Binder, Sharoda Dasgupta, Deborah L Dee, Emma S Jones, Jennifer L Kriss, B Casey Lyons, Meredith McMorrow, Daniel C Payne, Hannah E Reses, Loren E Rodgers, David Walker, Jennifer R Verani, Stephanie J Schrag (2022) <i>Lancet (London, England)</i> <i></i> <i></i> 399: 10320 152-160<br/>

//publicationslist.org/jrv/refid116 2026-04-01T22:28:14Z

The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and adolescents aged 5-11, 12-15, and 16-17 years (1-3). Limited real-world data on 2-dose mRNA vaccine effectiveness (VE) in persons aged 12-17 years (referred to as adolescents in this report) have also indicated high levels of protection against SAR...<br/><br/>Nicola P Klein, Melissa S Stockwell, Maria Demarco, Manjusha Gaglani, Anupam B Kharbanda, Stephanie A Irving, Suchitra Rao, Shaun J Grannis, Kristin Dascomb, Kempapura Murthy, Elizabeth A Rowley, Alexandra F Dalton, Malini B DeSilva, Brian E Dixon, Karthik Natarajan, Edward Stenehjem, Allison L Naleway, Ned Lewis, Toan C Ong, Palak Patel, Deepika Konatham, Peter J Embi, Sarah E Reese, Jungmi Han, Nancy Grisel, Kristin Goddard, Michelle A Barron, Monica Dickerson, I-Chia Liao, William F Fadel, Duck-Hye Yang, Julie Arndorfer, Bruce Fireman, Eric P Griggs, Nimish R Valvi, Carly Hallowell, Ousseny Zerbo, Sue Reynolds, Jill Ferdinands, Mehiret H Wondimu, Jeremiah Williams, Catherine H Bozio, Ruth Link-Gelles, Eduardo Azziz-Baumgartner, Stephanie J Schrag, Mark G Thompson, Jennifer R Verani (2022) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 71: 9 352-358<br/>

//publicationslist.org/jrv/refid95 2026-04-01T22:25:07Z

A high burden of Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) bacteremia has been reported from urban informal settlements in sub-Saharan Africa, yet little is known about the introduction of these strains to the region. Understanding regional differences in the predominant strains of S. Typhi can provide insight into the genomic epidemiology. We genetically characterized 310 S...<br/><br/>Caroline Ochieng, Jessica C Chen, Mike Powel Osita, Lee S Katz, Taylor Griswold, Victor Omballa, Eric Ng'eno, Alice Ouma, Newton Wamola, Christine Opiyo, Loicer Achieng, Patrick K Munywoki, Rene S Hendriksen, Molly Freeman, Matthew Mikoleit, Bonventure Juma, Godfrey Bigogo, Eric Mintz, Jennifer R Verani, Elizabeth Hunsperger, Heather A Carleton (2022) <i>PLoS neglected tropical diseases</i> <i></i> <i></i> 16: 8 <br/>

//publicationslist.org/jrv/refid96 2026-04-01T22:25:07Z

Nursing home residents have experienced disproportionally high levels of COVID-19-associated morbidity and mortality and were prioritized for early COVID-19 vaccination (1). Following reported declines in vaccine-induced immunity after primary series vaccination, defined as receipt of 2 primary doses of an mRNA vaccine (BNT162b2 [Pfizer-BioNTech] or mRNA-1273 [Moderna]) or 1 primary dose of Ad26.C...<br/><br/>Namrata Prasad, Gordana Derado, Srinivas Acharya Nanduri, Hannah E Reses, Heather Dubendris, Emily Wong, Minn Minn Soe, Qunna Li, Philip Dollard, Suparna Bagchi, Jonathan Edwards, Nong Shang, Dan Budnitz, Jeneita Bell, Jennifer R Verani, Andrea Benin, Ruth Link-Gelles, John Jernigan, Tamara Pilishvili (2022) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 71: 18 633-637<br/>

//publicationslist.org/jrv/refid94 2026-04-01T22:24:49Z

On September 1, 2022, bivalent COVID-19 mRNA vaccines, composed of components from the SARS-CoV-2 ancestral and Omicron BA.4/BA.5 strains, were recommended by the Advisory Committee on Immunization Practices (ACIP) to address reduced effectiveness of COVID-19 monovalent vaccines during SARS-CoV-2 Omicron variant predominance (1). Initial recommendations included persons aged ≥12 years (Pfizer-Bi...<br/><br/>Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E Fleming-Dutra, Zachary R Smith, Amadea Britton, Ryan E Wiegand, Joseph D Miller, Emma K Accorsi, Stephanie J Schrag, Jennifer R Verani, Nong Shang, Gordana Derado, Tamara Pilishvili (2022) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 71: 48 1526-1530<br/>

//publicationslist.org/jrv/refid91 2026-04-01T22:24:49Z

Acute respiratory illnesses (ARI) are a major cause of morbidity and mortality globally. With (re)emergence of novel viruses and increased access to childhood bacterial vaccines, viruses have assumed greater importance in the aetiology of ARI. There are now promising candidate vaccines against some of the most common endemic respiratory viruses. Optimal delivery strategies for these vaccines, and ...<br/><br/>Nickson Murunga, Bryan Nyawanda, Joyce U Nyiro, Grieven P Otieno, Everlyn Kamau, Charles N Agoti, Clement Lewa, Alex Gichuki, Martin Mutunga, Nancy Otieno, Lilian Mayieka, Melvin Ochieng, Gilbert Kikwai, Elizabeth Hunsperger, Clayton Onyango, Gideon Emukule, Godfrey Bigogo, Jennifer R Verani, Sandra S Chaves, D James Nokes, Patrick K Munywoki (2022) <i>Wellcome open research</i> <i></i> <i></i> 7: <br/>

//publicationslist.org/jrv/refid131 2026-04-01T22:30:42Z

Nursing home and long-term care facility residents live in congregate settings and are often elderly and frail, putting them at high risk for infection with SARS-CoV-2, the virus that causes COVID-19, and severe COVID-19-associated outcomes; therefore, this population was prioritized for early vaccination in the United States (1). Following rapid distribution and administration of the mRNA COVID-1...<br/><br/>Srinivas Nanduri, Tamara Pilishvili, Gordana Derado, Minn Minn Soe, Philip Dollard, Hsiu Wu, Qunna Li, Suparna Bagchi, Heather Dubendris, Ruth Link-Gelles, John A Jernigan, Daniel Budnitz, Jeneita Bell, Andrea Benin, Nong Shang, Jonathan R Edwards, Jennifer R Verani, Stephanie J Schrag (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 34 1163-1166<br/>

//publicationslist.org/jrv/refid121 2026-04-01T22:28:38Z

Salmonella Enteritidis and Salmonella Typhimurium are major causes of bloodstream infection and diarrheal disease in East Africa. Sources of human infection, including the role of the meat pathway, are poorly understood.<br/><br/>John A Crump, Kate M Thomas, Jackie Benschop, Matthew A Knox, David A Wilkinson, Anne C Midwinter, Peninah Munyua, John B Ochieng, Godfrey M Bigogo, Jennifer R Verani, Marc-Alain Widdowson, Gerard Prinsen, Sarah Cleaveland, Esron D Karimuribo, Rudovick R Kazwala, Blandina T Mmbaga, Emanuel S Swai, Nigel P French, Ruth N Zadoks (2021) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 73: 7 e1570-e1578<br/>

//publicationslist.org/jrv/refid130 2026-04-01T22:30:42Z

Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination can provide immunity and protection from subsequent SARS-CoV-2 infection and illness. CDC used data from the VISION Network* to examine hospitalizations in adults with COVID-19-like illness and compared the odds of receiving a positive SARS-CoV-2 test result, and thus having laboratory-confirmed COVID-19, b...<br/><br/>Catherine H Bozio, Shaun J Grannis, Allison L Naleway, Toan C Ong, Kristen A Butterfield, Malini B DeSilva, Karthik Natarajan, Duck-Hye Yang, Suchitra Rao, Nicola P Klein, Stephanie A Irving, Brian E Dixon, Kristin Dascomb, I-Chia Liao, Sue Reynolds, Charlene McEvoy, Jungmi Han, Sarah E Reese, Ned Lewis, William F Fadel, Nancy Grisel, Kempapura Murthy, Jill Ferdinands, Anupam B Kharbanda, Patrick K Mitchell, Kristin Goddard, Peter J Embi, Julie Arndorfer, Chandni Raiyani, Palak Patel, Elizabeth A Rowley, Bruce Fireman, Nimish R Valvi, Eric P Griggs, Matthew E Levy, Ousseny Zerbo, Rachael M Porter, Rebecca J Birch, Lenee Blanton, Sarah W Ball, Andrea Steffens, Natalie Olson, Jeremiah Williams, Monica Dickerson, Meredith McMorrow, Stephanie J Schrag, Jennifer R Verani, Alicia M Fry, Eduardo Azziz-Baumgartner, Michelle Barron, Manjusha Gaglani, Mark G Thompson, Edward Stenehjem (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 44 1539-1544<br/>

//publicationslist.org/jrv/refid132 2026-04-01T22:30:42Z

Maternal immunization is a key strategy for reducing morbidity and mortality associated with infectious diseases in mothers and their newborns. Recent developments in the science and safety of maternal vaccinations have made possible development of new maternal vaccines ready for introduction in low- and middle-income countries. Decisions at the policy level remain the entry point for maternal imm...<br/><br/>Nancy A Otieno, Fauzia A Malik, Stacy W Nganga, Winnie N Wairimu, Dominic O Ouma, Godfrey M Bigogo, Sandra S Chaves, Jennifer R Verani, Marc-Alain Widdowson, Andrew D Wilson, Irina Bergenfeld, Ines Gonzalez-Casanova, Saad B Omer (2021) <i>Implementation science : IS</i> <i></i> <i></i> 16: 1 <br/>

//publicationslist.org/jrv/refid142 2026-04-01T22:45:05Z

Throughout the COVID-19 pandemic, health care personnel (HCP) have been at high risk for exposure to SARS-CoV-2, the virus that causes COVID-19, through patient interactions and community exposure (1). The Advisory Committee on Immunization Practices recommended prioritization of HCP for COVID-19 vaccination to maintain provision of critical services and reduce spread of infection in health care s...<br/><br/>Tamara Pilishvili, Katherine E Fleming-Dutra, Jennifer L Farrar, Ryan Gierke, Nicholas M Mohr, David A Talan, Anusha Krishnadasan, Karisa K Harland, Howard A Smithline, Peter C Hou, Lilly C Lee, Stephen C Lim, Gregory J Moran, Elizabeth Krebs, Mark Steele, David G Beiser, Brett Faine, John P Haran, Utsav Nandi, Walter A Schrading, Brian Chinnock, Daniel J Henning, Frank LoVecchio, Joelle Nadle, Devra Barter, Monica Brackney, Amber Britton, Kaytlynn Marceaux-Galli, Sarah Lim, Erin C Phipps, Ghinwa Dumyati, Rebecca Pierce, Tiffanie M Markus, Deverick J Anderson, Amanda K Debes, Michael Lin, Jeanmarie Mayer, Hilary M Babcock, Nasia Safdar, Marc Fischer, Rosalyn Singleton, Nora Chea, Shelley S Magill, Jennifer Verani, Stephanie Schrag, (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 20 753-758<br/>

//publicationslist.org/jrv/refid32 2026-04-01T22:17:34Z

Understanding respiratory syncytial virus (RSV) circulation patterns is necessary to guide the timing of limited-duration interventions such as vaccines. We describe RSV circulation over multiple seasons in three distinct counties of Kenya during 2006-2018. Kilifi and Siaya counties each had consistent but distinct RSV seasonality, lasting on average 18-22 weeks. Based on data from available year...<br/><br/>Erica Billig Rose, Bryan O Nyawanda, Patrick K Munywoki, Nickson Murunga, Godfrey M Bigogo, Nancy A Otieno, Clayton Onyango, Sandra S Chaves, Jennifer R Verani, Gideon O Emukule, Marc-Alain Widdowson, D James Nokes, Susan I Gerber, Gayle E Langley (2021) <i>Influenza and other respiratory viruses</i> <i></i> <i></i> 15: 2 195-201<br/>

//publicationslist.org/jrv/refid141 2026-04-01T22:45:05Z

Prisons and jails are high-risk settings for COVID-19 transmission, morbidity, and mortality. COVID-19 vaccines may substantially reduce these risks, but evidence is needed of their effectiveness for incarcerated people, who are confined in large, risky congregate settings.<br/><br/>Elizabeth T Chin, David Leidner, Yifan Zhang, Elizabeth Long, Lea Prince, Stephanie J Schrag, Jennifer R Verani, Ryan E Wiegand, Fernando Alarid-Escudero, Jeremy D Goldhaber-Fiebert, David M Studdert, Jason R Andrews, Joshua A Salomon (2021) <i>medRxiv : the preprint server for health sciences</i> <i></i> <i></i> : <br/>

//publicationslist.org/jrv/refid140 2026-04-01T22:45:05Z

A comprehensive understanding of the benefits of COVID-19 vaccination requires consideration of disease attenuation, determined as whether people who develop COVID-19 despite vaccination have lower disease severity than unvaccinated people.<br/><br/>Mark W Tenforde, Wesley H Self, Katherine Adams, Manjusha Gaglani, Adit A Ginde, Tresa McNeal, Shekhar Ghamande, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Matthew C Exline, Michelle N Gong, Amira Mohamed, Daniel J Henning, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Caitlin C Ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Alexandra June Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Natasha Halasa, James D Chappell, Adam S Lauring, Carlos G Grijalva, Todd W Rice, Ian D Jones, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Jillian P Rhoads, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Samantha M Olson, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, (2021) <i>JAMA</i> <i></i> <i></i> 326: 20 2043-2054<br/>

//publicationslist.org/jrv/refid133 2026-04-01T22:31:07Z

Widespread global transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19), continues. Many questions remain about asymptomatic or atypical infections and transmission dynamics. We used comprehensive contact tracing of the first 2 confirmed patients in Illinois with COVID-19 and serologic SARS-CoV-2 antibody testing to dete...<br/><br/>Tristan D McPherson, Isaac Ghinai, Alison M Binder, Brandi D Freeman, Chantel Hoskin Snelling, Jennifer C Hunter, Kristin M Anderson, Polly Davenport, Deborah L Rudd, Mujeeb Zafer, Demian Christiansen, Kiran Joshi, Rachel Rubin, Stephanie R Black, Marielle J Fricchione, Massimo Pacilli, Kelly A Walblay, Jacqueline Korpics, Darcie Moeller, Pearl Quartey-Kumapley, Chen Wang, E Matt Charles, Judy Kauerauf, Megan T Patel, Vishal S Disari, Marc Fischer, Max W Jacobs, Sandra N Lester, Claire M Midgley, Mohammed Ata Ur Rasheed, Heather E Reese, Jennifer R Verani, Megan Wallace, John T Watson, Natalie J Thornburg, Jennifer E Layden, Hannah L Kirking (2021) <i>Public health reports (Washington, D.C. : 1974)</i> <i></i> <i></i> 136: 1 88-96<br/>

//publicationslist.org/jrv/refid120 2026-04-01T22:28:38Z

Mozambique introduced 10-valent pneumococcal conjugate vaccine (PCV10) in 2013 with doses at ages 2, 3, and 4 months and no catch-up or booster dose. We evaluated PCV10 impact on the carriage of vaccine-type (VT), non-VT, and antimicrobial non-susceptible pneumococci 3 years after introduction.<br/><br/>Sandra J Valenciano, Benild Moiane, Fernanda C Lessa, Alberto Chaúque, Sergio Massora, Fabiana C Pimenta, Helio Mucavele, Jennifer R Verani, Maria da Gloria Carvalho, Cynthia G Whitney, Nelson Tembe, Betuel Sigaúque (2021) <i>Journal of the Pediatric Infectious Diseases Society</i> <i></i> <i></i> 10: 4 448-456<br/>

//publicationslist.org/jrv/refid118 2026-04-01T22:28:14Z

Real-world evaluations have demonstrated high effectiveness of vaccines against COVID-19-associated hospitalizations (1-4) measured shortly after vaccination; longer follow-up is needed to assess durability of protection. In an evaluation at 21 hospitals in 18 states, the duration of mRNA vaccine (Pfizer-BioNTech or Moderna) effectiveness (VE) against COVID-19-associated hospitalizations was asses...<br/><br/>Mark W Tenforde, Wesley H Self, Eric A Naioti, Adit A Ginde, David J Douin, Samantha M Olson, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Michelle N Gong, Amira Mohamed, Daniel J Henning, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Caitlin C Ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Alexandra June Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Matthew C Exline, Natasha Halasa, James D Chappell, Adam S Lauring, Carlos G Grijalva, Todd W Rice, Ian D Jones, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Meagan Stephenson, Stephanie J Schrag, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, , (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 34 1156-1162<br/>

//publicationslist.org/jrv/refid119 2026-04-01T22:28:14Z

Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to inform real-world use. Such studies are now underway amid the ongoing rollout of SARS-CoV-2 vaccines globally. Although traditional case-control and test-negative design studies feature prominently among strategies used to assess vaccine effectiveness, such studies may encounter important threats to validity. ...<br/><br/>Joseph A Lewnard, Manish M Patel, Nicholas P Jewell, Jennifer R Verani, Miwako Kobayashi, Mark W Tenforde, Natalie E Dean, Benjamin J Cowling, Benjamin A Lopman (2021) <i>Epidemiology (Cambridge, Mass.)</i> <i></i> <i></i> 32: 4 508-517<br/>

//publicationslist.org/jrv/refid74 2026-04-01T22:20:52Z

Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1-3). In an evaluation at 24 hospitals in 14 states,* the effectiveness of partial or full vaccination with Pfizer-BioNTech or Moderna vaccines against COVID-1...<br/><br/>Mark W Tenforde, Samantha M Olson, Wesley H Self, H Keipp Talbot, Christopher J Lindsell, Jay S Steingrub, Nathan I Shapiro, Adit A Ginde, David J Douin, Matthew E Prekker, Samuel M Brown, Ithan D Peltan, Michelle N Gong, Amira Mohamed, Akram Khan, Matthew C Exline, D Clark Files, Kevin W Gibbs, William B Stubblefield, Jonathan D Casey, Todd W Rice, Carlos G Grijalva, David N Hager, Arber Shehu, Nida Qadir, Steven Y Chang, Jennifer G Wilson, Manjusha Gaglani, Kempapura Murthy, Nicole Calhoun, Arnold S Monto, Emily T Martin, Anurag Malani, Richard K Zimmerman, Fernanda P Silveira, Donald B Middleton, Yuwei Zhu, Dayna Wyatt, Meagan Stephenson, Adrienne Baughman, Kelsey N Womack, Kimberly W Hart, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, , (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 18 674-679<br/>

//publicationslist.org/jrv/refid29 2026-04-01T22:17:14Z

There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect to hospitalization, admission to an intensive care unit (ICU), or ambulatory care in an emergency department or urgent care clinic.<br/><br/>Mark G Thompson, Edward Stenehjem, Shaun Grannis, Sarah W Ball, Allison L Naleway, Toan C Ong, Malini B DeSilva, Karthik Natarajan, Catherine H Bozio, Ned Lewis, Kristin Dascomb, Brian E Dixon, Rebecca J Birch, Stephanie A Irving, Suchitra Rao, Elyse Kharbanda, Jungmi Han, Sue Reynolds, Kristin Goddard, Nancy Grisel, William F Fadel, Matthew E Levy, Jill Ferdinands, Bruce Fireman, Julie Arndorfer, Nimish R Valvi, Elizabeth A Rowley, Palak Patel, Ousseny Zerbo, Eric P Griggs, Rachael M Porter, Maria Demarco, Lenee Blanton, Andrea Steffens, Yan Zhuang, Natalie Olson, Michelle Barron, Patricia Shifflett, Stephanie J Schrag, Jennifer R Verani, Alicia Fry, Manjusha Gaglani, Eduardo Azziz-Baumgartner, Nicola P Klein (2021) <i>The New England journal of medicine</i> <i></i> <i></i> 385: 15 1355-1371<br/>

//publicationslist.org/jrv/refid28 2026-04-01T22:17:14Z

The prioritization of U.S. health care personnel for early receipt of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), allowed for the evaluation of the effectiveness of these new vaccines in a real-world setting.<br/><br/>Tamara Pilishvili, Ryan Gierke, Katherine E Fleming-Dutra, Jennifer L Farrar, Nicholas M Mohr, David A Talan, Anusha Krishnadasan, Karisa K Harland, Howard A Smithline, Peter C Hou, Lilly C Lee, Stephen C Lim, Gregory J Moran, Elizabeth Krebs, Mark T Steele, David G Beiser, Brett Faine, John P Haran, Utsav Nandi, Walter A Schrading, Brian Chinnock, Daniel J Henning, Frank Lovecchio, Jane Lee, Devra Barter, Monica Brackney, Scott K Fridkin, Kaytlynn Marceaux-Galli, Sarah Lim, Erin C Phipps, Ghinwa Dumyati, Rebecca Pierce, Tiffanie M Markus, Deverick J Anderson, Amanda K Debes, Michael Y Lin, Jeanmarie Mayer, Jennie H Kwon, Nasia Safdar, Marc Fischer, Rosalyn Singleton, Nora Chea, Shelley S Magill, Jennifer R Verani, Stephanie J Schrag, (2021) <i>The New England journal of medicine</i> <i></i> <i></i> 385: 25 <br/>

//publicationslist.org/jrv/refid72 2026-04-01T22:20:38Z

To evaluate if facility-level vaccination after an initial vaccination clinic was independently associated with COVID-19 incidence adjusted for other factors in January 2021 among nursing home residents.<br/><br/>Andrea L Benin, Minn M Soe, Jonathan R Edwards, Suparna Bagchi, Ruth Link-Gelles, Stephanie J Schrag, Kurt Herzer, Jennifer R Verani, Daniel Budnitz, Srinivas Nanduri, John Jernigan, Chris Edens, Radhika Gharpure, Anita Patel, Hsiu Wu, Beth C Golshir, Aaron Jaffe, Qunna Li, Arjun Srinivasan, Evan Shulman, Shari M Ling, Jean Moody-Williams, Lee A Fleisher, Daniel A Pollock, Jeneita Bell, (2021) <i>Journal of the American Medical Directors Association</i> <i></i> <i></i> 22: 10 2009-2015<br/>

//publicationslist.org/jrv/refid31 2026-04-01T22:17:24Z

The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype invasive pneumococcal disease among vaccine-eligible-age and vaccine-ineligible-age children and adults.<br/><br/>Naor Bar-Zeev, Todd D Swarthout, Dean B Everett, Maaike Alaerts, Jacquline Msefula, Comfort Brown, Sithembile Bilima, Jane Mallewa, Carina King, Anne von Gottberg, Jennifer R Verani, Cynthia G Whitney, Charles Mwansambo, Stephen B Gordon, Nigel A Cunliffe, Neil French, Robert S Heyderman, (2021) <i>The Lancet. Global health</i> <i></i> <i></i> 9: 7 e989-e998<br/>

//publicationslist.org/jrv/refid27 2026-04-01T22:16:57Z

The mRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech) provide strong protection against severe COVID-19, including hospitalization, for at least several months after receipt of the second dose (1,2). However, studies examining immune responses and differences in protection against COVID-19-associated hospitalization in real-world settings, including by vaccine product, are limited. To understan...<br/><br/>Kristina L Bajema, Rebecca M Dahl, Steve L Evener, Mila M Prill, Maria C Rodriguez-Barradas, Vincent C Marconi, David O Beenhouwer, Mark Holodniy, Cynthia Lucero-Obusan, Sheldon T Brown, Maraia Tremarelli, Monica Epperson, Lisa Mills, So Hee Park, Gilberto Rivera-Dominguez, Rosalba Gomez Morones, Ghazal Ahmadi-Izadi, Rijalda Deovic, Chad Mendoza, Chan Jeong, Stephanie J Schrag, Elissa Meites, Aron J Hall, Miwako Kobayashi, Meredith McMorrow, Jennifer R Verani, Natalie J Thornburg, Diya Surie, , , (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 49 1700-1705<br/>

//publicationslist.org/jrv/refid99 2026-04-01T22:25:07Z

Lower respiratory tract infections are a leading cause of death in young children, but few studies have collected the specimens needed to define the role of specific causes. The Child Health and Mortality Prevention Surveillance (CHAMPS) platform aims to investigate causes of death in children aged <5 years in high-mortality rate settings, using postmortem minimally invasive tissue sampling and ot...<br/><br/>Dianna M Blau, Vicky L Baillie, Toyah Els, Sana Mahtab, Portia Mutevedzi, Adama Mamby Keita, Karen L Kotloff, Ashka Mehta, Samba O Sow, Milagritos D Tapia, Beth A Tippett Barr, Benard O Oluoch, Clayton Onyango, Gunturu Revathi, Jennifer R Verani, Mahlet Abayneh, Nega Assefa, Lola Madrid, Joseph O Oundo, J Anthony G Scott, Quique Bassat, Inacio Mandomando, Antonio Sitoe, Marta Valente, Rosauro Varo, Ima-Abasi Bassey, Carrie Jo Cain, Amara Jambai, Ikechukwu Ogbuanu, Julius Ojulong, Muntasir Alam, Shams El Arifeen, Emily S Gurley, Afruna Rahman, Mustafizur Rahman, Jessica L Waller, Betsy Dewey, Robert F Breiman, Cynthia G Whitney, Shabir A Madhi, (2021) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 73: Suppl_3 S218-S228<br/>

//publicationslist.org/jrv/refid117 2026-04-01T22:28:14Z

Immunocompromised persons, defined as those with suppressed humoral or cellular immunity resulting from health conditions or medications, account for approximately 3% of the U.S. adult population (1). Immunocompromised adults are at increased risk for severe COVID-19 outcomes (2) and might not acquire the same level of protection from COVID-19 mRNA vaccines as do immunocompetent adults (3,4). To e...<br/><br/>Peter J Embi, Matthew E Levy, Allison L Naleway, Palak Patel, Manjusha Gaglani, Karthik Natarajan, Kristin Dascomb, Toan C Ong, Nicola P Klein, I-Chia Liao, Shaun J Grannis, Jungmi Han, Edward Stenehjem, Margaret M Dunne, Ned Lewis, Stephanie A Irving, Suchitra Rao, Charlene McEvoy, Catherine H Bozio, Kempapura Murthy, Brian E Dixon, Nancy Grisel, Duck-Hye Yang, Kristin Goddard, Anupam B Kharbanda, Sue Reynolds, Chandni Raiyani, William F Fadel, Julie Arndorfer, Elizabeth A Rowley, Bruce Fireman, Jill Ferdinands, Nimish R Valvi, Sarah W Ball, Ousseny Zerbo, Eric P Griggs, Patrick K Mitchell, Rachael M Porter, Salome A Kiduko, Lenee Blanton, Yan Zhuang, Andrea Steffens, Sarah E Reese, Natalie Olson, Jeremiah Williams, Monica Dickerson, Meredith McMorrow, Stephanie J Schrag, Jennifer R Verani, Alicia M Fry, Eduardo Azziz-Baumgartner, Michelle A Barron, Mark G Thompson, Malini B DeSilva (2021) <i>MMWR. Morbidity and mortality weekly report</i> <i></i> <i></i> 70: 44 1553-1559<br/>

//publicationslist.org/jrv/refid100 2026-04-01T22:25:07Z

Phase 3 randomized-controlled trials have provided promising results of COVID-19 vaccine efficacy, ranging from 50 to 95% against symptomatic disease as the primary endpoints, resulting in emergency use authorization/listing for several vaccines. However, given the short duration of follow-up during the clinical trials, strict eligibility criteria, emerging variants of concern, and the changing ep...<br/><br/>Minal K Patel, Isabel Bergeri, Joseph S Bresee, Benjamin J Cowling, Natasha S Crowcroft, Kamal Fahmy, Siddhivinayak Hirve, Gagandeep Kang, Mark A Katz, Claudio F Lanata, Maïna L'Azou Jackson, Sudhir Joshi, Marc Lipsitch, Jason M Mwenda, Francisco Nogareda, Walter A Orenstein, Justin R Ortiz, Richard Pebody, Stephanie J Schrag, Peter G Smith, Padmini Srikantiah, Lorenzo Subissi, Marta Valenciano, David W Vaughn, Jennifer R Verani, Annelies Wilder-Smith, Daniel R Feikin (2021) <i>Vaccine</i> <i></i> <i></i> 39: 30 4013-4024<br/>

//publicationslist.org/jrv/refid35 2026-04-01T22:17:43Z

Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated the first case of COVID-19 in Illinois, USA.<br/><br/>Isaac Ghinai, Tristan D McPherson, Jennifer C Hunter, Hannah L Kirking, Demian Christiansen, Kiran Joshi, Rachel Rubin, Shirley Morales-Estrada, Stephanie R Black, Massimo Pacilli, Marielle J Fricchione, Rashmi K Chugh, Kelly A Walblay, N Seema Ahmed, William C Stoecker, Nausheen F Hasan, Deborah P Burdsall, Heather E Reese, Megan Wallace, Chen Wang, Darcie Moeller, Jacqueline Korpics, Shannon A Novosad, Isaac Benowitz, Max W Jacobs, Vishal S Dasari, Megan T Patel, Judy Kauerauf, E Matt Charles, Ngozi O Ezike, Victoria Chu, Claire M Midgley, Melissa A Rolfes, Susan I Gerber, Xiaoyan Lu, Stephen Lindstrom, Jennifer R Verani, Jennifer E Layden, (2020) <i>Lancet (London, England)</i> <i></i> <i></i> 395: 10230 1137-1144<br/>

//publicationslist.org/jrv/refid33 2026-04-01T22:17:34Z

Influenza vaccination during pregnancy benefits mothers and children. Kenya and other low- and middle-income countries have no official influenza vaccination policies to date but are moving towards issuing such policies. Understanding determinants of influenza vaccine uptake during pregnancy in these settings is important to inform policy decisions and vaccination rollout.<br/><br/>Nancy A Otieno, Bryan Nyawanda, Fredrick Otiato, Maxwel Adero, Winnie N Wairimu, Raphael Atito, Andrew D Wilson, Ines Gonzalez-Casanova, Fauzia A Malik, Jennifer R Verani, Marc-Alain Widdowson, Saad B Omer, Sandra S Chaves (2020) <i>Vaccine</i> <i></i> <i></i> 38: 43 6832-6838<br/>

//publicationslist.org/jrv/refid38 2026-04-01T22:17:43Z

Rotavirus remains a leading cause of pediatric diarrheal illness and death worldwide. Data on rotavirus vaccine effectiveness in sub-Saharan Africa are limited. Kenya introduced monovalent rotavirus vaccine (RV1) in July 2014. We assessed RV1 effectiveness against rotavirus-associated hospitalization in Kenyan children.<br/><br/>Sammy Khagayi, Richard Omore, Grieven P Otieno, Billy Ogwel, John B Ochieng, Jane Juma, Evans Apondi, Godfrey Bigogo, Clayton Onyango, Mwanajuma Ngama, Regina Njeru, Betty E Owor, Mike J Mwanga, Yaw Addo, Collins Tabu, Anyangu Amwayi, Jason M Mwenda, Jacqueline E Tate, Umesh D Parashar, Robert F Breiman, D James Nokes, Jennifer R Verani (2020) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 70: 11 2298-2305<br/>

//publicationslist.org/jrv/refid73 2026-04-01T22:20:38Z

Maternal immunization is known to be one of the best strategies to protect both mothers and their infants from infectious diseases. Studies have shown that healthcare providers play a critical role in implementation of maternal immunization. However, little is known about providers' attitudes and beliefs towards vaccination that can influence their vaccine recommendations, specifically in low to m...<br/><br/>Subhash Chander, Ines Gonzalez-Casanova, Sandra S Chaves, Nancy A Otieno, Marc-Alain Widdowson, Jennifer Verani, Paula Frew, Andrew Wilson, Saad B Omer, Fauzia Malik (2020) <i>Gates open research</i> <i></i> <i></i> 4: <br/>

//publicationslist.org/jrv/refid101 2026-04-01T22:25:26Z

Globally, rotavirus group A (RVA) remains a major cause of severe childhood diarrhea, despite the use of vaccines in more than 100 countries. RVA sequencing for local outbreaks facilitates investigation into strain composition, origins, spread, and vaccine failure. In 2018, we collected 248 stool samples from children aged less than 13 years admitted with diarrheal illness to Kilifi County Hospita...<br/><br/>Mike J Mwanga, Jennifer R Verani, Richard Omore, Jacqueline E Tate, Umesh D Parashar, Nickson Murunga, Elijah Gicheru, Robert F Breiman, D James Nokes, Charles N Agoti (2020) <i>Pathogens (Basel, Switzerland)</i> <i></i> <i></i> 9: 12 <br/>

//publicationslist.org/jrv/refid102 2026-04-01T22:25:26Z

Coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. In response to the first cases identified in the United States, close contacts of confirmed COVID-19 cases were investigated to enable early identification and isolation of additional cases and to le...<br/><br/>Rachel M Burke, Sharon Balter, Emily Barnes, Vaughn Barry, Karri Bartlett, Karlyn D Beer, Isaac Benowitz, Holly M Biggs, Hollianne Bruce, Jonathan Bryant-Genevier, Jordan Cates, Kevin Chatham-Stephens, Nora Chea, Howard Chiou, Demian Christiansen, Victoria T Chu, Shauna Clark, Sara H Cody, Max Cohen, Erin E Conners, Vishal Dasari, Patrick Dawson, Traci DeSalvo, Matthew Donahue, Alissa Dratch, Lindsey Duca, Jeffrey Duchin, Jonathan W Dyal, Leora R Feldstein, Marty Fenstersheib, Marc Fischer, Rebecca Fisher, Chelsea Foo, Brandi Freeman-Ponder, Alicia M Fry, Jessica Gant, Romesh Gautom, Isaac Ghinai, Prabhu Gounder, Cheri T Grigg, Jeffrey Gunzenhauser, Aron J Hall, George S Han, Thomas Haupt, Michelle Holshue, Jennifer Hunter, Mireille B Ibrahim, Max W Jacobs, M Claire Jarashow, Kiran Joshi, Talar Kamali, Vance Kawakami, Moon Kim, Hannah L Kirking, Amanda Kita-Yarbro, Rachel Klos, Miwako Kobayashi, Anna Kocharian, Misty Lang, Jennifer Layden, Eva Leidman, Scott Lindquist, Stephen Lindstrom, Ruth Link-Gelles, Mariel Marlow, Claire P Mattison, Nancy McClung, Tristan D McPherson, Lynn Mello, Claire M Midgley, Shannon Novosad, Megan T Patel, Kristen Pettrone, Satish K Pillai, Ian W Pray, Heather E Reese, Heather Rhodes, Susan Robinson, Melissa Rolfes, Janell Routh, Rachel Rubin, Sarah L Rudman, Denny Russell, Sarah Scott, Varun Shetty, Sarah E Smith-Jeffcoat, Elizabeth A Soda, Christopher Spitters, Bryan Stierman, Rebecca Sunenshine, Dawn Terashita, Elizabeth Traub, Grace M Vahey, Jennifer R Verani, Megan Wallace, Matthew Westercamp, Jonathan Wortham, Amy Xie, Anna Yousaf, Matthew Zahn (2020) <i>PloS one</i> <i></i> <i></i> 15: 9 <br/>

//publicationslist.org/jrv/refid103 2026-04-01T22:25:26Z

Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A multisite study was established in 2 population-based surveillance sites to evaluate vaccine impact on the incidence of rotavirus-associated hospitalizations (RVHs).<br/><br/>Grieven P Otieno, Christian Bottomley, Sammy Khagayi, Ifedayo Adetifa, Mwanajuma Ngama, Richard Omore, Billy Ogwel, Betty E Owor, Godfrey Bigogo, John B Ochieng, Clayton Onyango, Jane Juma, Jason Mwenda, Collins Tabu, Jacqueline E Tate, Yaw Addo, Tuck Britton, Umesh D Parashar, Robert F Breiman, Jennifer R Verani, D James Nokes (2020) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 70: 11 2306-2313<br/>

//publicationslist.org/jrv/refid75 2026-04-01T22:20:52Z

Pneumococcal conjugate vaccine (PCV) and rotavirus vaccine (RV) are key tools for reducing common causes of infant mortality. However, measurement of population-level mortality impact is lacking from sub-Saharan Africa. We evaluated mortality impact and vaccine effectiveness (VE) of PCV13 introduced in November 2011, with subsequent RV1 roll-out in October 2012, in Malawi.<br/><br/>Carina King, Naor Bar-Zeev, Tambosi Phiri, James Beard, Hazzie Mvula, Amelia Crampin, Ellen Heinsbroek, Dan Hungerford, Sonia Lewycka, Jennifer Verani, Cynthia Whitney, Anthony Costello, Charles Mwansambo, Nigel Cunliffe, Rob Heyderman, Neil French, (2020) <i>BMJ global health</i> <i></i> <i></i> 5: 9 <br/>

//publicationslist.org/jrv/refid36 2026-04-01T22:17:43Z

Pregnant women and newborns are at high risk for infectious diseases. Altered immunity status during pregnancy and challenges fully vaccinating newborns contribute to this medical reality. Maternal immunization is a strategy to protect pregnant women and their newborns. This study aimed to find out how patient-provider relationships affect maternal vaccine uptake, particularly in the context of a ...<br/><br/>Stacy W Nganga, Nancy A Otieno, Maxwell Adero, Dominic Ouma, Sandra S Chaves, Jennifer R Verani, Marc-Alain Widdowson, Andrew Wilson, Irina Bergenfeld, Courtni Andrews, Vincent L Fenimore, Ines Gonzalez-Casanova, Paula M Frew, Saad B Omer, Fauzia A Malik (2019) <i>BMC health services research</i> <i></i> <i></i> 19: 1 <br/>

//publicationslist.org/jrv/refid78 2026-04-01T22:21:17Z

Data on pneumococcal conjugate vaccine (PCV) indirect effects in low-income countries with high human immunodeficiency virus (HIV) burden are limited. We examined adult pneumococcal pneumonia incidence before and after PCV introduction in Kenya in 2011.<br/><br/>Godfrey M Bigogo, Allan Audi, Joshua Auko, George O Aol, Benjamin J Ochieng, Herine Odiembo, Arthur Odoyo, Marc-Alain Widdowson, Clayton Onyango, Martien W Borgdorff, Daniel R Feikin, Maria da Gloria Carvalho, Cynthia G Whitney, Jennifer R Verani (2019) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 69: 12 2177-2184<br/>

//publicationslist.org/jrv/refid34 2026-04-01T22:17:43Z

Antibiotics are essential to treat for many childhood bacterial infections; however inappropriate antibiotic use contributes to antimicrobial resistance. For childhood diarrhea, empiric antibiotic use is recommended for dysentery (bloody diarrhea) for which first-line therapy is ciprofloxacin. We assessed inappropriate antibiotic prescription for childhood diarrhea in two primary healthcare facili...<br/><br/>Chulwoo Rhee, George Aol, Alice Ouma, Allan Audi, Shadrack Muema, Joshua Auko, Richard Omore, George Odongo, Ryan E Wiegand, Joel M Montgomery, Marc-Alain Widdowson, Ciara E O'Reilly, Godfrey Bigogo, Jennifer R Verani (2019) <i>BMC public health</i> <i></i> <i></i> 19: Suppl 3 <br/>

//publicationslist.org/jrv/refid77 2026-04-01T22:21:17Z

Worldwide, the number of emerging and re-emerging infectious diseases is increasing, highlighting the importance of global disease pathogen surveillance. Traditional population-based methods may fail to capture important events, particularly in settings with limited access to health care, such as urban informal settlements. In such environments, a mixture of surface water runoff and human feces co...<br/><br/>Rene S Hendriksen, Oksana Lukjancenko, Patrick Munk, Mathis H Hjelmsø, Jennifer R Verani, Eric Ng'eno, Godfrey Bigogo, Samuel Kiplangat, Traoré Oumar, Lasse Bergmark, Timo Röder, John C Neatherlin, Onyango Clayton, Tine Hald, Susanne Karlsmose, Sünje J Pamp, Barry Fields, Joel M Montgomery, Frank M Aarestrup (2019) <i>PloS one</i> <i></i> <i></i> 14: 10 <br/>

//publicationslist.org/jrv/refid76 2026-04-01T22:20:52Z

The impact of influenza B virus circulation in Sub-Saharan Africa is not well described.<br/><br/>Gideon O Emukule, Fredrick Otiato, Bryan O Nyawanda, Nancy A Otieno, Caroline A Ochieng, Linus K Ndegwa, Peter Muturi, Godfrey Bigogo, Jennifer R Verani, Philip M Muthoka, Elizabeth Hunsperger, Sandra S Chaves (2019) <i>Open forum infectious diseases</i> <i></i> <i></i> 6: 10 <br/>

//publicationslist.org/jrv/refid37 2026-04-01T22:17:43Z

Invasive pneumococcal disease (IPD) is a significant cause of morbidity and mortality among children worldwide. In April 2013, Mozambique introduced 10-valent PCV (PCV10) into the National Expanded Program on immunization using a three-dose schedule at 2, 3, and 4 months of age. We aimed to evaluate the invasive disease potential of pneumococcal serotypes among children in our region before and ...<br/><br/>Sérgio Massora, Fernanda C Lessa, Benild Moiane, Fabiana C Pimenta, Hélio Mucavele, Alberto Chaúque, Anélsio Cossa, Jennifer R Verani, Nelson Tembe, Maria da Gloria Carvalho, Carmen Muñoz-Almagro, Betuel Sigaúque (2019) <i>Vaccine</i> <i></i> <i></i> 37: 51 7470-7477<br/>

//publicationslist.org/jrv/refid39 2026-04-01T22:18:00Z

Acute respiratory infection (ARI) is an important cause of mortality in children and adults. However, studies assessing risk factors for ARI-related deaths in low- and middle-income settings are limited. We describe ARI-related death and associated factors among children aged < 2 years and adults aged ≥18 years hospitalized with ARI in Guatemala.<br/><br/>Sara Tomczyk, John P McCracken, Carmen Lucia Contreras, Maria Renee Lopez, Chris Bernart, Juan Carlos Moir, Kenneth Escobar, Lisette Reyes, Wences Arvelo, Kim Lindblade, Leonard Peruski, Joe P Bryan, Jennifer R Verani (2019) <i>BMC public health</i> <i></i> <i></i> 19: 1 <br/>

//publicationslist.org/jrv/refid80 2026-04-01T22:21:17Z

Invasive pneumococcal disease (IPD) is a major cause of illness and death among children worldwide. 10-valent pneumococcal conjugate vaccine (PCV10) was introduced as part of the Mozambican routine immunization program in April 2013. We characterized the IPD burden in a rural area of Mozambique before PCV introduction and estimated the potential impact of this intervention.<br/><br/>Betuel Sigaúque, Jennifer R Verani, Sérgio Massora, Delfino Vubil, Llorenç Quintó, Sozinho Acácio, Inácio Mandomando, Quique Bassat, Tacilta Nhampossa, Fabiana Pimenta, Charfudin Sacoor, Maria da Gloria Carvalho, Eusebio Macete, Pedro L Alonso (2018) <i>PloS one</i> <i></i> <i></i> 13: 1 <br/>

//publicationslist.org/jrv/refid104 2026-04-01T22:25:26Z

Nasopharyngeal carriage is a precursor for pneumococcal disease and can be useful for evaluating pneumococcal conjugate vaccine (PCV) impact. We studied pre-PCV pneumococcal carriage among HIV-infected and -uninfected children in Mozambique. Between October 2012 and March 2013, we enrolled HIV-infected children age <5 years presenting for routine care at seven HIV clinics in 3 sites, including Map...<br/><br/>Jennifer R Verani, Sérgio Massora, Sozinho Acácio, Rita Teresa Dos Santos, Delfino Vubil, Fabiana Pimenta, Iaci Moura, Cynthia G Whitney, Maria Helena Costa, Eusébio Macete, Maria Benigna Matsinhe, Maria da Gloria Carvalho, Betuel Sigaúque (2018) <i>PloS one</i> <i></i> <i></i> 13: 2 <br/>

//publicationslist.org/jrv/refid122 2026-04-01T22:28:38Z

Expansion of maternal immunization, which offers some of the most effective protection against morbidity and mortality in pregnant women and neonates, requires broad acceptance by healthcare providers and their patients. We aimed to describe issues surrounding acceptance and demand creation for maternal vaccines in Kenya from a provider perspective. Nurses and clinical officers were recruited fo...<br/><br/>Irina Bergenfeld, Stacy W Nganga, Courtni A Andrews, Vincent L Fenimore, Nancy A Otieno, Andrew D Wilson, Sandra S Chaves, Jennifer R Verani, Marc-Alain Widdowson, Winnie N Wairimu, Susan N Wandera, Raphael O Atito, Maxwell O Adero, Paula M Frew, Saad B Omer, Fauzia A Malik (2018) <i>Gates open research</i> <i></i> <i></i> 2: <br/>

//publicationslist.org/jrv/refid79 2026-04-01T22:21:17Z

Because anemia is one of the markers of morbidity associated with schistosomiasis, it has been proposed as a potential measure to evaluate the impact of control programs. However, anemia is also a common consequence of malaria, and schistosomiasis and malaria are often co-endemic. To estimate the attributable fraction of anemia due to and infections, we applied a log-binomial model to four studi...<br/><br/>Emily M Valice, Ryan E Wiegand, Pauline N M Mwinzi, Diana M S Karanja, John M Williamson, Elizabeth Ochola, Aaron Samuels, Jennifer R Verani, Juan S Leon, W Evan Secor, Susan P Montgomery (2018) <i>The American journal of tropical medicine and hygiene</i> <i></i> <i></i> 99: 3 713-715<br/>

//publicationslist.org/jrv/refid42 2026-04-01T22:18:00Z

Non-typhoidal Salmonella (NTS) is a leading cause of bloodstream infections in Africa, but the various contributions of host susceptibility versus unique pathogen virulence factors are unclear. We used data from a population-based surveillance platform (population ~25,000) between 2007-2014 and NTS genome-sequencing to compare host and pathogen-specific factors between individuals presenting with ...<br/><br/>Adam Akullian, Joel M Montgomery, Grace John-Stewart, Samuel I Miller, Hillary S Hayden, Matthew C Radey, Kyle R Hager, Jennifer R Verani, John Benjamin Ochieng, Jane Juma, Jim Katieno, Barry Fields, Godfrey Bigogo, Allan Audi, Judd Walson (2018) <i>PLoS neglected tropical diseases</i> <i></i> <i></i> 12: 1 <br/>

//publicationslist.org/jrv/refid40 2026-04-01T22:18:00Z

Pneumococcal carriage is a precursor of invasive pneumococcal disease. Mozambique introduced 10-valent pneumococcal conjugate vaccine (PCV10) in April 2013, using a 3-dose schedule without a booster. We evaluated PCV10 impact on pneumococcal carriage and colonization density by HIV status.<br/><br/>Betuel Sigaúque, Benild Moiane, Sergio Massora, Fabiana Pimenta, Jennifer R Verani, Helio Mucavele, Alberto Chaúque, Llorenç Quintó, Rita T Dos Santos, Maria da Gloria Carvalho, Cynthia G Whitney, Fernanda C Lessa (2018) <i>The Pediatric infectious disease journal</i> <i></i> <i></i> 37: 10 1054-1060<br/>

//publicationslist.org/jrv/refid41 2026-04-01T22:18:00Z

Limited data are available on the effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in resource-poor settings and PCV naïve populations. The Dominican Republic introduced PCV13 in September 2013 using a 2 + 1 schedule (2, 4, and 12 months) without a catch-up campaign. We evaluated PCV13 effectiveness against vaccine-type (VT) invasive pneumococcal disease (IPD) among children...<br/><br/>Sara Tomczyk, Fernanda C Lessa, Jacqueline Sánchez, Chabela Peña, Josefina Fernández, M Gloria Carvalho, Fabiana Pimenta, Doraliza Cedano, Cynthia G Whitney, Jennifer R Verani, Hilma Coradin, Zacarías Garib, Lucia Helena De Oliveira, Jesús Feris-Iglesias (2018) <i>BMC infectious diseases</i> <i></i> <i></i> 18: 1 <br/>

//publicationslist.org/jrv/refid143 2026-04-01T22:45:05Z

To assess the impact of immunization with pneumococcal conjugate vaccines on all-cause pneumonia hospitalizations among children in Soweto, South Africa.<br/><br/>Alane Izu, Fatima Solomon, Susan A Nzenze, Azwifarwi Mudau, Elizabeth Zell, Katherine L O'Brien, Cynthia G Whitney, Jennifer Verani, Michelle Groome, Shabir A Madhi (2017) <i>Bulletin of the World Health Organization</i> <i></i> <i></i> 95: 9 618-628<br/>

//publicationslist.org/jrv/refid82 2026-04-01T22:21:17Z

Case-control studies are commonly used to evaluate effectiveness of licensed vaccines after deployment in public health programs. Such studies can provide policy-relevant data on vaccine performance under 'real world' conditions, contributing to the evidence base to support and sustain introduction of new vaccines. However, case-control studies do not measure the impact of vaccine introduction on ...<br/><br/>Jennifer R Verani, Abdullah H Baqui, Claire V Broome, Thomas Cherian, Cheryl Cohen, Jennifer L Farrar, Daniel R Feikin, Michelle J Groome, Rana A Hajjeh, Hope L Johnson, Shabir A Madhi, Kim Mulholland, Katherine L O'Brien, Umesh D Parashar, Manish M Patel, Laura C Rodrigues, Mathuram Santosham, J Anthony Scott, Peter G Smith, Halvor Sommerfelt, Jacqueline E Tate, J Chris Victor, Cynthia G Whitney, Anita K Zaidi, Elizabeth R Zell (2017) <i>Vaccine</i> <i></i> <i></i> 35: 25 3295-3302<br/>

//publicationslist.org/jrv/refid134 2026-04-01T22:31:07Z

In the U.S., intrapartum antibiotic prophylaxis (IAP) for pregnant women colonized with group B streptococcus (GBS) has reduced GBS disease in the first week of life (early-onset/EOGBS). Nonetheless, GBS remains a leading cause of neonatal sepsis, including 1000 late-onset (LOGBS) cases annually. A maternal vaccine under development could prevent EOGBS and LOGBS.<br/><br/>Sun-Young Kim, Chi Nguyen, Louise B Russell, Sara Tomczyk, Fatimah Abdul-Hakeem, Stephanie J Schrag, Jennifer R Verani, Anushua Sinha (2017) <i>Vaccine</i> <i></i> <i></i> 35: 45 6238-6247<br/>

//publicationslist.org/jrv/refid81 2026-04-01T22:21:17Z

We assessed knowledge and practices related to antibiotic use in Kibera, an urban informal settlement in Kenya. Surveys was employed at the beginning (entry) and again at the end (exit) of a 5-month longitudinal study of AMR. Two-hundred households were interviewed at entry, of which 149 were also interviewed at exit. The majority (>65%) of respondents in both surveys could name at least one antib...<br/><br/>Sylvia Omulo, Samuel M Thumbi, Svetlana Lockwood, Jennifer R Verani, Godfrey Bigogo, Geoffrey Masyongo, Douglas R Call (2017) <i>PloS one</i> <i></i> <i></i> 12: 10 <br/>

//publicationslist.org/jrv/refid43 2026-04-01T22:18:00Z

A maternal group B streptococcal (GBS) vaccine could prevent neonatal sepsis and meningitis. Its cost-effectiveness in low-income sub-Saharan Africa, a high burden region, is unknown.<br/><br/>Louise B Russell, Sun-Young Kim, Ben Cosgriff, Sri Ram Pentakota, Stephanie J Schrag, Ajoke Sobanjo-Ter Meulen, Jennifer R Verani, Anushua Sinha (2017) <i>Vaccine</i> <i></i> <i></i> 35: 49 Pt B 6905-6914<br/>

//publicationslist.org/jrv/refid44 2026-04-01T22:18:22Z

Data on neonatal group B streptococcal (GBS) invasive disease burden are needed to refine prevention policies. Differences in surveillance methods and investigating for cases can lead to varying disease burden estimates. We compared the findings of laboratory-based passive surveillance for GBS disease across South Africa, and for one of the provinces compared this to a real-time, systematic, clini...<br/><br/>Vanessa Quan, Jennifer R Verani, Cheryl Cohen, Anne von Gottberg, Susan Meiring, Clare L Cutland, Stephanie J Schrag, Shabir A Madhi (2016) <i>PloS one</i> <i></i> <i></i> 11: 4 <br/>

//publicationslist.org/jrv/refid123 2026-04-01T22:28:38Z

To describe the clinical presentation and outcomes of Acanthamoeba keratitis (AK) in rigid gas permeable (RGP) contact lens wearers and to identify modifiable risk factors.<br/><br/>Jennifer R Cope, Sarah A Collier, Oliver D Schein, Allison C Brown, Jennifer R Verani, Rachel Gallen, Michael J Beach, Jonathan S Yoder (2016) <i>Ophthalmology</i> <i></i> <i></i> 123: 7 1435-1441<br/>

//publicationslist.org/jrv/refid105 2026-04-01T22:25:26Z

In order to better understand respiratory syncytial virus (RSV) epidemiology and burden in tropical Africa, optimal case definitions for detection of RSV cases need to be identified.<br/><br/>Bryan O Nyawanda, Joshua A Mott, Henry N Njuguna, Lilian Mayieka, Sammy Khagayi, Reuben Onkoba, Caroline Makokha, Nancy A Otieno, Godfrey M Bigogo, Mark A Katz, Daniel R Feikin, Jennifer R Verani (2016) <i>BMC infectious diseases</i> <i></i> <i></i> 16: <br/>

//publicationslist.org/jrv/refid83 2026-04-01T22:21:17Z

Group B streptococcus (GBS) is a leading neonatal sepsis pathogen globally. Investment in GBS disease prevention, such as maternal vaccination, requires evidence of disease burden, particularly in high infant mortality regions like sub-Saharan Africa. We aimed to provide such evidence by conducting a systematic literature review and meta-analysis to estimate maternal colonization proportion, GBS d...<br/><br/>Anushua Sinha, Louise B Russell, Sara Tomczyk, Jennifer R Verani, Stephanie J Schrag, James A Berkley, Musa Mohammed, Betuel Sigauque, Sun-Young Kim, (2016) <i>The Pediatric infectious disease journal</i> <i></i> <i></i> 35: 9 933-942<br/>

//publicationslist.org/jrv/refid135 2026-04-01T22:31:07Z

Streptococcus pneumoniae is a leading cause of pneumonia worldwide. However, the burden of pneumococcal pneumonia among adults in low- and middle-income countries is not well described.<br/><br/>Carmen Lucía Contreras, Jennifer R Verani, María Renee Lopez, Antonio Paredes, Chris Bernart, Fabiola Moscoso, Aleida Roldan, Wences Arvelo, Kim A Lindblade, John P McCracken (2015) <i>PloS one</i> <i></i> <i></i> 10: 10 <br/>

//publicationslist.org/jrv/refid144 2026-04-01T22:45:05Z

We applied the indirect cohort method to estimate effectiveness of 10-valent pneumococcal conjugate vaccine (PCV10) among young children in Brazil. Cases of invasive pneumococcal disease (IPD), i.e., Streptococcus pneumoniae, detected in normally sterile fluid identified through laboratory-based surveillance and previously enrolled in a matched case-control effectiveness study are included. We est...<br/><br/>Jennifer R Verani, Carla Magda A Santos Domingues, José Cassio de Moraes, (2015) <i>Vaccine</i> <i></i> <i></i> 33: 46 6145-6148<br/>

//publicationslist.org/jrv/refid46 2026-04-01T22:18:31Z

In March 2010, Brazil introduced the ten-valent pneumococcal conjugate vaccine (PCV10), which was licensed based on non-inferiority of immunological correlates of protection compared with the seven-valent vaccine. The schedule comprised three primary doses at ages 2 months, 4 months, and 6 months, and a booster dose at age 12 months. A single catch-up dose was offered for children aged 12-23 month...<br/><br/>Carla Magda Allan S Domingues, Jennifer R Verani, Ernesto Issac Montenegro Renoiner, Maria Cristina de Cunto Brandileone, Brendan Flannery, Lucia Helena de Oliveira, João Barberino Santos, José Cássio de Moraes, (2014) <i>The Lancet. Respiratory medicine</i> <i></i> <i></i> 2: 6 464-471<br/>

//publicationslist.org/jrv/refid45 2026-04-01T22:18:31Z

Pleural effusion is a serious complication of pneumonia, and is a leading cause. We describe the aetiology of pneumonia with effusion among children in the Dominican Republic before the introduction of the 13-valent pneumococcal conjugate vaccine (PCV) in 2013 and the performance characteristics of a rapid immunochromatographic test (ICT) for detecting in pleural fluid. From July 2009 to June 20...<br/><br/>Jesús Feris-Iglesias, Josefina Fernández, Jacqueline Sánchez, Fabiana Pimenta, Chabela Peña, Hilma Coradin, Eddy Perez-Then, Maria Peinado, Angélica Floren, Teresa Del Moral, Dean Erdman, Maria da Gloria Carvalho, Jennifer R Verani (2014) <i>Pneumonia (Nathan Qld.)</i> <i></i> <i></i> 4: 8-15<br/>

//publicationslist.org/jrv/refid106 2026-04-01T22:25:39Z

To describe lapses in adherence to group B streptococcus (GBS) prevention guidelines among cases of early-onset GBS disease in term and preterm neonates and to estimate the potential for further reduction in disease burden under current prevention strategies.<br/><br/>Jennifer R Verani, Nancy L Spina, Ruth Lynfield, William Schaffner, Lee H Harrison, Amy Holst, Stepy Thomas, Jessica M Garcia, Karen Scherzinger, Deborah Aragon, Susan Petit, Jamie Thompson, Lauren Pasutti, Roberta Carey, Lesley McGee, Emily Weston, Stephanie J Schrag (2014) <i>Obstetrics and gynecology</i> <i></i> <i></i> 123: 4 828-837<br/>

//publicationslist.org/jrv/refid47 2026-04-01T22:18:31Z

In 2007, the World Health Organization published the Global Framework for Immunization Monitoring and Surveillance (GFIMS) outlining measures to enhance national surveillance for vaccine preventable diseases (VPDs). The GFIMS emphasized that VPD surveillance should be integrated and placed in a 'unified framework' building upon the strengths of existing surveillance systems to prevent duplication ...<br/><br/>Terri B Hyde, Jon K Andrus, Vance J Dietz, , Carla E Lee, Marc-Alain Widdowson, Jennifer R Verani, Cindy Friedman, Eduardo Azziz-Baumgartner, Adriana S Lopez, Aisha Jumaan (2013) <i>Vaccine</i> <i></i> <i></i> 31 Suppl 3: 0 3 C94-C98<br/>

//publicationslist.org/jrv/refid124 2026-04-01T22:28:38Z

Group B Streptococcus (GBS) emerged as the leading cause of newborn infection in the United States in the 1970s. In the 1980s clinical trials demonstrated that giving intrapartum intravenous ampicillin or penicillin to mothers at risk was highly effective at preventing invasive GBS disease in the first week of life (early-onset). In 1996, the first national guidelines for the prevention of perinat...<br/><br/>Stephanie J Schrag, Jennifer R Verani (2013) <i>Vaccine</i> <i></i> <i></i> 31 Suppl 4: Suppl 4 D20-D26<br/>

//publicationslist.org/jrv/refid107 2026-04-01T22:25:39Z

The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into the routine immunization program in Uruguay in March 2008 with a 2-dose primary series (given at 2 and 4 months) plus a booster (at 12 months) and a catch-up campaign (two doses given at 15 and 17 months). We used a case-control methodology and existing laboratory surveillance and immunization registry data from Uruguay to eval...<br/><br/>Teresa Picón, Lucía Alonso, Gabriela García Gabarrot, Noelia Speranza, Mariana Casas, Fernando Arrieta, Teresa Camou, Raquel Rosa, Lucia Helena De Oliveira, Jennifer Rabke Verani (2013) <i>Vaccine</i> <i></i> <i></i> 31 Suppl 3: Suppl 3 C109-C113<br/>

//publicationslist.org/jrv/refid48 2026-04-01T22:18:31Z

Haemophilus influenzae type b (Hib) conjugate vaccine has dramatically reduced invasive Hib disease worldwide. Yet, data on protection against pneumonia and among children with HIV are limited. We evaluated the impact of Hib conjugate vaccine introduction in 2009 in a rural, high-HIV prevalence area in Mozambique.<br/><br/>Betuel Sigaúque, Delfino Vubil, Acacio Sozinho, Llorenç Quintó, Luís Morais, Charfudin Sacoor, Maria G Carvalho, Jennifer R Verani, Pedro L Alonso, Anna Roca (2013) <i>The Journal of pediatrics</i> <i></i> <i></i> 163: 1 Suppl S19-S24<br/>

//publicationslist.org/jrv/refid145 2026-04-01T22:45:05Z

To describe the trend of Acanthamoeba keratitis case reports following an outbreak and the recall of a multipurpose contact lens disinfection solution. Acanthamoeba keratitis is a serious eye infection caused by the free-living amoeba Acanthamoeba that primarily affects contact lens users.<br/><br/>Jonathan S Yoder, Jennifer Verani, Nancy Heidman, Joan Hoppe-Bauer, Eduardo C Alfonso, Darlene Miller, Dan B Jones, David Bruckner, Roger Langston, Bennie H Jeng, Charlotte E Joslin, Elmer Tu, Kathryn Colby, Emily Vetter, David Ritterband, William Mathers, Regis P Kowalski, Nisha R Acharya, Ajit P Limaye, Charles Leiter, Sharon Roy, Suchita Lorick, Jacquelin Roberts, Michael J Beach (2012) <i>Ophthalmic epidemiology</i> <i></i> <i></i> 19: 4 221-225<br/>

//publicationslist.org/jrv/refid84 2026-04-01T22:21:29Z

Pneumonia is a leading cause of morbidity and mortality worldwide. Effective vaccine and non-vaccine interventions to prevent and control pneumonia are urgently needed to reduce the global burden of the disease. This paper explores practical strategies and policies for integrating interventions to prevent and treat pneumonia with routine immunization services, and it investigates the challenges in...<br/><br/>Adam L Cohen, Terri B Hyde, Jennifer Verani, Margaret Watkins (2012) <i>Bulletin of the World Health Organization</i> <i></i> <i></i> 90: 4 289-294<br/>

//publicationslist.org/jrv/refid136 2026-04-01T22:31:07Z

Knowledge from early outbreaks is limited regarding the virus detection and illness duration of the 2009 pandemic influenza A (H1N1) infections. During the period from April to May 2009 in Texas, we collected serial nasopharyngeal (NP) and stool specimens from 35 participants, testing by real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) and culture. The participants were aged 2 m...<br/><br/>Anil Suryaprasad, Oliver W Morgan, Patrick Peebles, Agnes Warner, Tara K Kerin, Mathew D Esona, Michael D Bowen, Wendy Sessions, Xiyan Xu, Theresa Cromeans, Fatimah Dawood, Trudi Shim, Manoj Menon, Jennifer R Verani, Dean Erdman, Stephen Lindstrom, Vincent P Fonseca, Alicia M Fry, Sonja J Olsen (2011) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 52 Suppl 1: S109-S115<br/>

//publicationslist.org/jrv/refid50 2026-04-01T22:18:40Z

Although schistosomiasis burden is greatest among school-age children (SAC) (6-15 years of age), infection among preschool-age children (PSAC) (1-5 years), may be underestimated in endemic areas. We conducted a cross-sectional study evaluating Schistosoma mansoni infection among children 1-15 years of age in a highly endemic community in Kenya. Diagnostic tests included stool exam (Kato/Katz techn...<br/><br/>Jennifer R Verani, Bernard Abudho, Susan P Montgomery, Pauline N M Mwinzi, Hillary L Shane, Sara E Butler, Diana M S Karanja, W Evan Secor (2011) <i>The American journal of tropical medicine and hygiene</i> <i></i> <i></i> 84: 5 787-791<br/>

//publicationslist.org/jrv/refid108 2026-04-01T22:25:39Z

San Antonio, Texas, was one of the first metropolitan areas where 2009 pandemic influenza A (H1N1) virus (pH1N1) was detected. Identification of laboratory-confirmed pH1N1 in 2 students led to a preemptive 8-day closure of their high school. We assessed transmission of pH1N1 and changes in adoption of nonpharmaceutical interventions (NPIs) within households of students attending the affected schoo...<br/><br/>Fleetwood Loustalot, Benjamin J Silk, Amber Gaither, Trudi Shim, Mark Lamias, Fatimah Dawood, Oliver W Morgan, Daniel Fishbein, Sandra Guerra, Jennifer R Verani, Susan A Carlson, Vincent P Fonseca, Sonja J Olsen (2011) <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> <i></i> <i></i> 52 Suppl 1: S146-S153<br/>

//publicationslist.org/jrv/refid85 2026-04-01T22:21:29Z

To assess household transmission of pandemic (H1N1) 2009 in San Antonio, Texas, USA, during April 15-May 8, 2009, we investigated 77 households. The index case-patient was defined as the household member with the earliest onset date of symptoms of acute respiratory infection (ARI), influenza-like illness (ILI), or laboratory-confirmed pandemic (H1N1) 2009. Median interval between illness onset in ...<br/><br/>Oliver W Morgan, Sharyn Parks, Trudi Shim, Patricia A Blevins, Pauline M Lucas, Roger Sanchez, Nancy Walea, Fleetwood Loustalot, Mark R Duffy, Matthew J Shim, Sandra Guerra, Fernando Guerra, Gwen Mills, Jennifer Verani, Bryan Alsip, Stephen Lindstrom, Bo Shu, Shannon Emery, Adam L Cohen, Manoj Menon, Alicia M Fry, Fatimah Dawood, Vincent P Fonseca, Sonja J Olsen (2010) <i>Emerging infectious diseases</i> <i></i> <i></i> 16: 4 631-637<br/>

//publicationslist.org/jrv/refid86 2026-04-01T22:21:29Z

Acanthamoebae are free-living amoebae found in the environment, including soil, freshwater, brackish water, seawater, hot tubs, and Jacuzzis. Acanthamoeba species can cause keratitis, a painful vision-threatening infection of the cornea, and fatal granulomatous encephalitis in humans. More than 20 species of Acanthamoeba belonging to morphological groups I, II, and III distributed in 15 genotypes ...<br/><br/>Stephanie P Johnston, Rama Sriram, Yvonne Qvarnstrom, Sharon Roy, Jennifer Verani, Jonathan Yoder, Suchita Lorick, Jacquelin Roberts, Michael J Beach, Govinda Visvesvara (2009) <i>Journal of clinical microbiology</i> <i></i> <i></i> 47: 7 2040-2045<br/>

//publicationslist.org/jrv/refid52 2026-04-01T22:18:40Z

Chagas disease affects 8-11 million people throughout the Americas. Early detection is crucial for timely treatment and to prevent non-vectorial transmission. Recombinant antigen-based rapid tests had high sensitivity and specificity in laboratory evaluations, but no Peruvian specimens were included in previous studies. We evaluated Stat-Pak and Trypanosoma Detect rapid tests in specimens from Bol...<br/><br/>Jennifer R Verani, Amy Seitz, Robert H Gilman, Carlos LaFuente, Gerson Galdos-Cardenas, Vivian Kawai, Elizabeth de LaFuente, Lisbeth Ferrufino, Natalie M Bowman, Viviana Pinedo-Cancino, Michael Z Levy, Francis Steurer, Charles W Todd, Louis V Kirchhoff, Lilia Cabrera, Manuela Verastegui, Caryn Bern (2009) <i>The American journal of tropical medicine and hygiene</i> <i></i> <i></i> 80: 3 410-415<br/>

//publicationslist.org/jrv/refid109 2026-04-01T22:25:39Z

An outbreak of Acanthamoeba keratitis, a rare, potentially blinding, corneal infection, was detected in the United States in 2007; cases had been increasing since 2004. A case-control study was conducted to investigate the outbreak. We interviewed 105 case-patients from 30 states and 184 controls matched geographically and by contact lens use. Available contact lenses, cases, solutions, and cornea...<br/><br/>Jennifer R Verani, Suchita A Lorick, Jonathan S Yoder, Michael J Beach, Christopher R Braden, Jacquelin M Roberts, Craig S Conover, Sue Chen, Kateesha A McConnell, Douglas C Chang, Benjamin J Park, Dan B Jones, Govinda S Visvesvara, Sharon L Roy, (2009) <i>Emerging infectious diseases</i> <i></i> <i></i> 15: 8 1236-1242<br/>

//publicationslist.org/jrv/refid53 2026-04-01T22:18:48Z

In 2002, the Advisory Committee on Immunization Practices recommended universal influenza vaccination of 6- to 23-month-olds. Little is known about coverage and missed opportunities for influenza vaccination at inner-city practices. The objective of this study was to assess the 2000-2001 to 2004-2005 coverage and the prevalence of missed opportunities for influenza vaccination among inner-city chi...<br/><br/>Jennifer R Verani, Matilde Irigoyen, Shaofu Chen, Frank Chimkin (2007) <i>Pediatrics</i> <i></i> <i></i> 119: 3 e580-e586<br/>

//publicationslist.org/jrv/refid87 2026-04-01T22:22:29Z

We studied microsporidiosis in human immunodeficiency virus-positive patients in 2 Lima hospitals. Of 2652 patients, 66% were male, 6% received antiretroviral therapy (ART), and the median CD4 lymphocyte count was 131 cells/microL. Sixty-seven patients (3%) had microsporidiosis; stool specimens from 56 were identified as having Enterocytozoon bieneusi of 10 different genotypes. The 2 most common g...<br/><br/>Caryn Bern, Vivian Kawai, Daniel Vargas, Jennifer Rabke-Verani, John Williamson, Raul Chavez-Valdez, Lihua Xiao, Irshad Sulaiman, Aldo Vivar, Eduardo Ticona, Marco Navincopa, Vitaliano Cama, Hercules Moura, W Evan Secor, Govinda Visvesvara, Robert H Gilman (2005) <i>The Journal of infectious diseases</i> <i></i> <i></i> 191: 10 1658-1664<br/>